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The Schafmeister research group has developed a technology for synthesizing bis-peptide 
oligomers that adopt well defined structure dependent upon the rich stereochemistry of the independent 
bis-amino acid monomers used in its construction.  These bis-amino acid monomers are designed to 
construct rigid bis-peptide scaffolds by utilizing a pair of amide bonds that form a 2,5 diketopiperazine 
(DKP) ring linkage between two monomers.  It is hoped to be able to precisely position functionality 
within our rigid scaffolds so as to allow us to explore potential applications with our bis-peptide 
oligomers.  Developing new bis-amino acid monomers will help achieve this goal.  The first part of this 
thesis outlines the synthesis of the pip5(2R5R) and pip5(2R5S) bis-amino acid monomers.  The newly 
synthesized pip5(2R5S) monomer was then coupled into a bis-peptide sequence with the previously 
synthesized pip5(2S5R) monomer.  Molecular modeling predicted that this particular sequence 
formed a tight turn in space; a useful structural motif for the exploration of small cavities and 
clefts.  The solution structure of this bis-peptide oligomer was determined by 2D-NMR 
techniques including a ROESY to determine important close contact information between 
protons on the same monomer and protons on adjacent monomers.  In addition, two powerful 
2D-NMR techniques that have begun their integration into our lab for structure determination 
were used to provide more NMR restraints on the bis-peptide structural model.  These included 
amplitude-constrained multiplet evaluation of 3JHH coupling constants and the use of residual dipolar 
coupling (RDC) constants.  Lastly, I have recently begun work on synthesizing a glucose sensitive 
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molecular actuator.  This molecular actuator is a water-soluble rod-hinge-rod motif that converts from its 
disordered “open” form to an ordered “closed” form upon reversible binding to glucose through the 4,6 
and 1,2 diol pairs.  It is envisioned that these rod-hinge-rod motifs can eventually be used for potential 
applications such as nanovalves. 
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1.0  INTRODUCTION AND BACKGROUND 
1.1 INTRODUCTION TO MY WORK 
Over the last decade there has been a rapidly emerging field of science encompassing a wide area 
of interests including medicine, physics, engineering, biology, and chemistry.1  This 
revolutionary field of nanotechnology has and will spur continual advances in our current 
technology which includes computer technology, medical diagnostic equipment, high-
performance robotics, and maybe even energy independence from major industrial nations.1  
There still remains tremendous amount of progress to be made, but moderate advances have 
given keen insight into the world that can revolve around such a technology. 
Nanotechnology is defined by the National Nanotechnology Initiative website2 as “the 
understanding and control of matter at dimensions of roughly 1 to 100 nanometers, where unique 
phenomena enable novel applications.”  At this particular “nano-scale regime”, the fundamental 
properties of materials tend to differ from their particular properties at the atomic level or the 
bulk material.    
It is the goal of nanotechnology to learn how to harness these characteristic properties so 
as to create molecules with unique chemical, physical, and biological functions.  In order to 
accomplish this task it becomes necessary to control the architecture of these nano-scale 
molecules.  But how does one create functional molecules while controlling the exact structure to 
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be within the “nano-scale regime”?  In the realm of materials science, many groups are 
continuing to work on this task of synthesizing and assembling small molecules with certain 
function or characteristics ultimately creating molecular devices and machines.  Solving these 
aforementioned problems has led to the development of many new areas of chemistry as well as 
unique approaches for constructing important macromolecules.  A small selection of these 
approaches will be summarized here. 
1.2 SUPRAMOLECULAR CHEMISTRY-MOLECULAR 
RECOGNITION AND SENSING 
Supramolecular chemistry offers a way of creating macromolecules that avoids the 
complications of chemical synthesis.  Supramolecular chemistry is a discipline that utilizes 
reversible interactions such as hydrogen bonding, electrostatic interactions, π- π interactions, 
metal coordination, hydrophobic forces, and van der Walls forces instead of covalent bonding.  
Areas explored by this discipline include host-guest chemistry, self-assembly, and molecular 
recognition.   
One of the earlier goals of supramolecular chemistry was to selectively complex cationic 
species.  Professor Jean-Marie Lehn has helped to pioneer this field and has continued to add 
interesting examples of dynamic devices.  Lehn and co-workers3 have developed an assembly of 
ion-regulated substrate binders.  These pyridine triads exist in a “W-shaped” conformation that 
undergoes a switching mechanism to a “U-shaped” cavity upon the addition Zn(II) cations.  
These Zn(II) cations facilitate the receptor to act as a molecular tweezer that binds to a 1,10-
phenantholine substrate (Figure 1). 
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Figure 1 (adapted from ref 3):  Representation of the pyridine triad in the “W-shaped” 
conformation in the presence of Zn(II) bound to a 1,10 phenantholine substrate molecule.3 
 
They also synthesized an analogous system containing a central pyrimidine ring.3 This 
particular receptor is initially in the “U-shaped” conformation for substrate binding.  Upon 
addition of Cu(I), the “U-shaped” conformation of the receptor is disrupted and converted into 
the “W-shaped” conformation that is incapable of binding an electron acceptor.   
Jeppesen, Sessler and co-workers4 have also utilized reversible molecular recognition via 
addition of ions.  This supramolecular host system is a tetra-tetrathiafulvalene calix[4]pyrrole 
that acts as a receptor for neutral electron acceptors such as tetrafluoro-ρ-benzoquinone forming 
a 1:2 complex of receptor to substrate (Figure 2).  In the absence of an anion, the tetra-TTF 
calix[4]pyrrole exists in a 1,3-alternate conformation with two arms pointing in opposite 
directions that each bind a substrate molecule.  However, the addition of chloride anions results 
in the release of the substrate as the Cl- facilitates a conformational change to a cone structure 
(Figure 2).4 
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Figure 2 (adapted from ref 4): Cartoon representation illustrating the change in 
conformation with the addition and removal of chloride anions to a CH2Cl2 solution of the 
tetra-TTF Calix[4]pyrrole and the electron-deficient guest tetrafluoro-ρ-benzoquinone 
(green rectangle).4 
 
1.3 MOLECULAR DEVICES AND MACHINES 
The idea of using molecular recognition via the use of weak interactions has been put to 
extended uses in the construction of molecular devices and molecular machines.  Stoddart and 
co-workers may be best known for their work with catenanes and rotaxanes.5 They have 
specialized in designing these movable elements to be controlled by external stimuli such as pH, 
electricity, and light.  Recently they have developed a pH-driven supramolecular valve by 
utilizing the immobilization of a diaklyammonium-tethers to porous silica with 
dibenzo[24]crown-8 (DB24C8).6   
This device is operated by trapping luminescent probe molecules (coumarin 460) in the 
diakylammonium tethered pores of the silica and capping these filled pores with DB24C8 via the 
formation of hydrogen bonds.  Treatment with base changes the protonation state of the tethers 
disrupting the H-bonds and releasing the coumarin 460.6 
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Another impressive example of an assembled molecular machine has been the 
construction of an azobenzene-modified nanoporous membrane (Figure 3) presented by Brinker 
and co-workers.7  This elegant construction utilized the properties of azobenzene to photo-
convert to an extended “trans” form upon irradiation with visible light (435 nm) and to a more 
bent “cis” form upon irradiation with UV light (360nm).  An azobenzene functionalized 
nanoporous membrane was mounted to an indinium tin oxide (ITO) electrode. The 
photoresponsive azobenzene was able to regulate the flow of ferrocene compounds to the 
electrode.  When in the extended “trans” form the pore size is decreased and when photo-
converted to the “cis” form the pore size increased thus increasing flow and increasing current at 
the ITO electrode.7 
 
 
 
 
 
 
 
Figure 3 (adapted from ref 7): Azobenzene functionalized pores will open in response to 
ultraviolet irradiation and close in response to visible light irradiation. The closed pores in 
state A slow the flow of electrochemically active ferrocenes (red circles) to the ITO 
electrode.  The open pores in state B allow higher transport to the electrodes and result in a 
measurable current at the ITO electrode.7 
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1.4 MODULAR APPROACH TO NANO-SCALE MOLECULES 
A brief look into nature immediately tells us that it is capable of creating functional 
macromolecules that carry out critical life functions in our bodies ranging from catalysis, to self 
replication, to molecular transportation.  Nature has done this by utilizing amino acids and 
nucleotides as monomers (building blocks) to create elegant proteins with a predetermined 
function as well as DNA and RNA that make life possible.  These impressive macromolecules 
are able to fold into precise secondary, tertiary, and quaternary structure by utilizing a network of 
specific interactions.  In a way to mimic the actions of nature, many groups have developed a 
modular approach of covalently linking together small monomers that collectively assemble a 
functional macromolecule.  In addition to solely modular synthesis, some groups have utilized 
the presence of secondary interactions to stabilize certain secondary structures in ways analogous 
to proteins thus generating certain architectures. 
A number of groups are attempting to synthesize specific architectures by utilizing 
designer dendrimers.  Another approach developed by Michl8 and co-workers utilizes a 
“Tinkertoy” construction set of trigonal and tetragonal connectors with metal-ligating termini 
that can piece together to create large macromolecules with certain functions.   
A large collection of modular approaches to macromolecule design fall under the heading 
of foldamers.  A foldamer is a discrete chain molecule or oligomer that adopts secondary 
structure stabilized by non-covalent interactions such as hydrogen-bonding.  These artificial 
molecules are capable of forming helices and β-sheets and have found uses in self-assembly, 
molecular recognition, and host-guest chemistry. 
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Moore and co-workers have developed shape-persistent molecules9,10 by connecting 
phenylene-ethynylene monomers as building blocks.  With this modular approach they have 
developed new functionalized monomers that are able to create macrocycles (Figure 4) with 
defined non-polar or slightly polar cavities.9,10  More recently, Moore and co-workers11 have 
developed helical structures that contain functionalized inner cavities by using a N,N-
(dimethylamino)pyridine monomer which directs its pyridine nitrogen into the inner cavity 
(Figure 5). 
 
Figure 4 (adapted from ref 10): Representative template directed synthesis of phenylene-
ethynylene macrocycle. 
 
  
Figure 5 (adapted from ref 11): Schematic representation of functionalized helical cavities. 
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Another leader in foldamer development is Samuel Gellman with the creation of his β-
peptides.  Since first discovering in 199912 that hexa-β-peptides composed of trans-2-
aminocyclohexanecarboxlyic acid (ACHC) adopt a 14-helix conformation in water, Gellman and 
co-workers have successfully developed β-sheets13 as well as hairpin turns.14  In addition this 
group has successfully synthesized β-peptide inhibitors of human cytomegalovirus entry.15 
Gellman’s β-peptide foldamers represent a promising approach to the task of synthesizing 
macromolecules with the ability to synthesize many oligomers with a few β-amino acids.  
However, the ability to accurately predict the exact folding properties of these relatively short 
oligomers severely limits the capacity of this technique when attempting to create larger and 
more intricate macromolecules. 
1.5 SCHAFMEISTER APPROACH TO DESIGNER NANOSCALE 
MACROMOLECULES 
This problem of predicting folding properties has been ongoing in the area of producing 
unnatural proteins.  However, significant progress has been made in this area of de novo 
design17,18, but the protein folding problem is far from being resolved in the production of 
unnatural proteins.  It is this idea of bypassing these folding problems that has spurred a 
revolutionary design of bis-amino acid oligomers that adopt well defined structure dependent 
upon the rich stereochemistry of the independent bis-amino acid monomers used in its 
construction.  By eliminating the problem of predicting complex folding patterns, it is envisioned 
that we will be capable of producing large macromolecules with precisely defined structure and 
functionality.  
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These bis-amino acid monomers (Figure 6) are designed to construct rigid scaffolds by 
utilizing a pair of amide bonds that form a 2,5 diketopiperazine (DKP) ring linkage between two 
monomers.  The overall structure of a chosen oligomer is dependent upon the exact 
stereochemistry of each bis-amino acid monomer, the order of sequence of the monomers, and 
the inherent nature of the monomer to adopt a particular ring conformation.   
 
 
 
 
 
 
 
 
Figure 6: Bis-amino acid monomers synthesized to date in our lab. 
There has been several structural characterization studies19-22 performed on homo- and 
hetero-oligomers synthesized with these monomers, and it is our hope to be to able to rationally 
design and predict the exact architecture of any oligomer synthesized based upon the information 
we learn in structural studies.   
We wish to ultimately be able to create large cavities and clefts similar to those described 
previously without the need of external stimuli to induce binding.  The research project presented 
here begins with the task of synthesizing the pip5(2R5R) and pip5(2R5S) bis-amino acid 
monomers.  The newly synthesized pip5(2R5S) and the previously synthesized pip5(2S5R) 
monomers were used in the construction of a curved hetero-oligomer in order to gain more 
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insight into bis-peptide sequences that are capable of forming cavities and clefts.  The structural 
characterization of this particular bis-peptide sequence led to the use of two structural elucidation 
techniques that have recently begun their integration in our lab.  These techniques will aid our 
structural studies as well as help demonstrate our ability to rationally design architectures.  These 
techniques include the use of amplitude-constrained multiplet evaluation for 3JHH coupling 
constants, and the use of residual dipolar coupling to determine the molecular conformation or 
shape of a molecule by relating two distant ends or parts of the molecule. 
The structural development of useful bis-peptide oligomers lays a foundation upon which 
we can create useful and functional macromolecules.  The future of our group is in the 
development of useful applications with these architecturally designed macromolecules. 
Therefore, the latter part of this document details the development of a potential application 
opens a gateway to constructing important nano-scale devices. 
One such device is the construction of a molecularly actuated glucose sensor that consists 
of a rod-hinge-rod motif.  These actuators possess a controlled mechanism that can reversibly 
switch between a disordered “open” form and an ordered “closed” form through the reversible 
binding to glucose.  Such a device can lead to the development of our own nanopore channels.  
By functionalizing nanoporous membranes with these molecular actuators we can form nano-
scale valves (Figure 7) that control the transport of insulin. 
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Figure 7: Molecular valves formed by attaching glucose sensitive molecular actuators to the 
insides of ~ 10 nanometer diameter alumina channels. At low glucose (yellow) 
concentrations the actuators will be disordered and block the channel (“valveclosed” state). 
In the presence of high glucose concentrations, the actuators will fold back, creating a 
channel with a diameter of about 5 nanometers, large enough to allow small proteins such 
as insulin to pass through (“valve-open” state).  
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2.0  SYNTHESIS OF PIPECOLIC ACID MONOMERS AND 
SECOND GENERATION PYRROLIDINE ACID MONOMERS 
2.1 SYNTHESIS OF PIP5(2R5R) AND PIP5(2R5S) MONOMERS 
As discussed in the previous chapter, our goal is to create macromolecules with defined tertiary 
structure.  Our approach utilizes the assembly of cyclic bis-amino acid monomers that are 
coupled through two pairs of amide bonds forming 2,5 diketopiperazine ring linkages.  These 
rigid ladder-type molecules create uniquely defined structures based on the rich stereochemistry 
of each individual monomer.  Achieving more control over structural design is dependent on the 
number and types of bis-amino acid monomers in our “molecular tool box”.  For an oligomer 
containing N number of monomers (using our 7 different monomers), the total number of 
possible combinations is 7N.  In our lab 7 monomers had been developed and utilized in the 
design of oligomers and hetero-oligomers.  The synthesis of pip5(2R5R) and pip5(2R5S) 
monomers will further enhance and diversify the tool box available for macromolecule synthesis. 
 
Scheme 1: Ketone 2.2 is synthesized in four easy steps from trans-4-hydroxy-L-proline with 
a yield of 37%.  
 
37% yield 
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O
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O
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The synthesis of these particular monomers is straight forward as it parallels that of their 
previously developed monomers.23 Ketone 2.220 (Scheme 1) was synthesized from readily 
available, inexpensive trans-4-hydroxy-L-proline.  
 
Scheme 2: Synthesis of ketone 2.5.  
 
  Compound 2.2 was subjected to a two-step cyclic ketone homologation reaction24 
(Scheme 2) yielding a mixture of two regioisomeric ketones 2.3 and 2.4.  The initial step 
involved a ring expansion24 reaction with ethyl diazo acetate in the presence of the lewis acid 
BF3.Et2O at 0 °C.  The mixture of  2.3 and 2.4 was purified by flash chromatography on SiO2 gel 
with a 5-30% EtOAc in hexanes gradient to remove colored impurities before performing a 
Krapcho decarbethoxylation25 generating a mixture of 2.5 and 2.6.  These two regioisomeric 
ketones were separated by flash chromatography on SiO2 gel with a 5-30% EtOAc in hexanes 
gradient.  Ketone 2.5 is the desired intermediate for both pip5(2R5R) and pip5(2R5S) monomers 
and was identified by comparing the 1H NMR spectra of its enantiomer that was previously 
synthesized in our lab.23 
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Scheme 3: Synthesis of bis-Boc protected hydantoins 2.9 and 2.10.  
Ketone 2.5 next underwent the Bucherer-Bergs reaction26 (Scheme 3) in order to create a 
quaternary stereocenter that can be eventually converted to the second amino acid.  Hydantoins 
2.7 and 2.8 were generated in a 3:2 ratio determined by 1H NMR of the crude mixture.  
Unfortunately, these hydantoins are inseparable by SiO2 gel chromatography23.  It is necessary to 
bis-Boc protect 2.7 and 2.8 to form 2.9 and 2.10 which are separable by SiO2 gel 
chromatography.  These bis-Boc protected hydantoins were separated by flash chromatography 
on SiO2 gel with a 5-30% EtOAc in hexanes gradient. 
 
 
2.2 STEREOCHEMICAL ASSIGNMENT OF BIS-BOC PROTECTED 
HYDANTOINS 
In order to verify the stereochemistry of 2.9 and 2.10, the Boc groups must be removed so as to 
be able to observe NOE interactions between the amide hydrogen and diastereotopic hydrogens 
on the six-membered ring.  Boc protecting groups of 2.9 and 2.10 were removed with exposure 
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to a 3:7 mixture of TFA in DCM for 3 hours with stirring (Scheme 4).  The tert-butyl protecting 
group is also labile to these conditions and was removed, yielding deprotected hydantoins 2.11 
and 2.12.   
Scheme 4: Deprotection of bis-Boc protected hydantoins to 2.11 and 2.12. 
2D COSY and 2D ROESY experiments were performed for compounds 2.11 and 2.12 in 
DMSO on a 500 MHz NMR in order to assign individual hydrogen resonances and to measure 
important NOE interactions (Figure 8).  ROESY analysis revealed correlations between amide 
hydrogen H1 with H6α and H10α but not 9α for 2.11.  Hydantoin 2.12 gives rise to ROESY 
correlations between amide H1 with H6β, H9β, and H10β.   
    
 
 
 
 
Figure 8: Lowest energy conformations of 2.11 and 2.12 determined in vacuo by carrying 
out a stochastic search27 with an MMFF94x forcefield using molecular mechanics package 
MOE.28 
 
The molecular mechanics package MOE28 was used to carry out a stochastic 
conformational search27 of hydantoins 2.11 and 2.12 in order to locate the lowest MMFF94x29-32 
energy minima in vacuo (Figure 8).  The modeled structures of the global energy minimum for 
both 2.11 and 2.12 are in strong agreement with their observed ROESY correlations.  In addition, 
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the observed correlations are in exact agreement with the previously developed pip5(2S5S) and 
pip5(2S5R) monomers23 thus absolutely determining the stereochemical assignment of bis-Boc 
protected hydantoins 2.9 and 2.10. 
2.3 FINISHED SYNTHESIS OF PIP5(2R5R) AND PIP5(2R5S) 
MONOMERS 
 
Scheme 5: Synthesis of the final pip5(2R5R) monomer, 2.17. 
Bis-Boc protected hydantoin 2.9 was hydrolyzed34 to the following amino acid 2.13 by stirring 
with 50% 2M KOH in THF for 45 minutes (Scheme 5).  The aqueous layer was separated and 
cooled to 0 °C.  The product was precipitated by dropwise addition of 2M HCl with pH 
adjustment to 6.5.  Oven dried 2.13 was converted to Fmoc protected 2.14 via a two step process 
with TMSCl and Fmoc-Cl.  Product 2.14 was purified by flash chromatography on SiO2 gel with 
a 0-10% MeoH in CHCl3 gradient. 
Recent work in our lab23 has demonstrated that oligomers constructed with pip5(2S5S) 
monomers that contain methyl esters undergo a base-catalyzed DKP closure at very slow rates.  
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Therefore, pip5 monomers with methyl esters are not viable for oligomer synthesis.  However, 
2,2,3,3-tetrafluoropropyl esters have been found to be more susceptible to DKP closure under 
acidic conditions.35  Therefore 2,2,3,3-tetrafluoropropyl ester versions of the pip5(2R5R) and 
pip5(2R5S) monomers were synthesized.  Compound 2.14 was esterified with 2,2,3,3-
tetrafluoropropyl alcohol in the presence of DCC and DMAP yielding a orthoganol protected 
2.15.  Product 2.15 was purified by flash chromatography on SiO2 gel with a 0-50% EtOAc in 
hexanes gradient. Subsequently, the tert-butyl protecting group was removed with 50% TFA in 
DCM, and the resulting deprotected product 2.16 purified by flash chromatography on SiO2 gel 
with a 0-10 % MeOH in CHCl3 gradient.   
Finally, a one pot Cbz to Boc exchange reaction36 was utilized transforming compound 
2.16 to the orthogonally protected compound 2.17.  This final building block was purified by 
flash chromatography on SiO2 gel with a 0-10% MeOH in CHCl3 gradient. 
 
 
Scheme 6: Synthesis of final the pip5(2R5S) monomer, 2.22. 
 
An identical strategy to Scheme 5 was followed in the production of the diastereomer 
pip5(2R5S) (2.22).  Scheme 6 outlines the synthesis of orthoganally protected 2.22, which was 
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subsequentally purified flash chromatography on SiO2 gel with a 0-10% MeOH in CHCl3 
gradient. 
2.4 SYNTHESIS OF 2ND GENERATION PRO4(2R4R) MONOMER (TFP 
VERSION) 
In the construction of hetero-oligomers containing pip5 monomers and pro4 monomers it is 
important to have identical leaving groups in the aminolysis reactions of the DKP closure.  When 
a pip5(2S5S) monomer is coupled to the N-terminus of a pro4(2S4S) monomer, the DKP closure 
between these two monomers is a very slow process.35  Therefore, the construction of  
pro4(2R4R) 2,2,3,3-tetrafluorpropyl ester generation monomers (Scheme 7) has been undertaken 
for the incorporation of these monomers into hetero-oligomers with pip5(2S5S), pip5(2S5R), 
pip5(2R5R), and pip5(2R5S) monomers. 
Scheme 7: Synthesis of the pro4(2R4R) TFP ester generation monomer, 2.26. 
  
Intermediate 2.2320 was esterified to 2.24 with 2,2,3,3-tetrafluoropropyl alcohol in the 
presence of DCC and DMAP yielding fully, orthogonally protected 2.24.  Product 2.24 was 
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immediately purified by flash chromatography on SiO2 gel with a 0-50% EtOAc in hexanes 
gradient.  The tert-butyl protecting group was removed with 50% TFA in DCM, and the 
resulting deprotected product 2.25 was purified by flash chromatography on SiO2 gel with a 0-
10% MeOH in CHCl3 gradient.  Finally, the Cbz protecting group was exchanged for a Boc 
group via a one pot procedure36 yielding 2.26 which was subsequentally purified by flash 
chromatography on SiO2 gel with a 0-10% MeOH in CHCl3 gradient. 
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3.0  STRUCTURAL ELUCIDATION OF CURVED HETERO-
OLIGOMER 
3.1 INTRODUCTION AND BACKGROUND 
As discussed in Chapter 1, one goal of our group is to construct large cavities and clefts that are 
capable of binding small target substrate molecules.  The synthesis of curved bis-peptide 
oligomers will aid in achieving this goal.  This chapter discusses the synthesis of one such 
curved hetero-oligomer that utilizes two bis-amino acid monomers that had not been used in the 
construction of any bis-peptide oligomer to date.  These pip5(2R5R) and pip5(2R5S) monomers 
were used to synthesize the pip5(2S5R)-pip5(2R5S)-pro4(2S4S)-(L)-tyrosine hetero-oligomer 
with standard Fmoc-solid phase peptide synthesis on the hydroxymethyl polystyrene resin.  The 
lowest energy conformer of oligomer 3.1 determined in vacuo when using the Amber9437 
forcefield shows a highly curved structure shown in Figure 9. 
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Figure 9: Lowest energy conformer of 3.1 in vacuo when carrying out a stochastic search27 
with an Amber9437 forcefield using the molecular mechanics package MOE.28 
 
It is this solution structure of bis-peptide 3.1 that I set to determine by using 2D-NMR 
experiments.  I carried out a TOCSY, an HSQC and an HMBC experiment and used the data to 
assign every carbon and hydrogen on the molecule.  I also carried out a ROESY experiment and 
observed several cross-peaks that indicate close contacts between hydrogen atoms within 
monomers as well as between monomers.  In addition, two NMR techniques that our group has 
recently learned to use have aided in the structural determination of 3.1.  The extraction of 3JHH 
coupling constants from a phase sensitive COSY provided important dihedral angle information 
regarding the ring conformation of each monomer.  Also, recently our group has demonstrated 
the ability to use residual dipolar coupling (RDC) constants as additional NMR restraints on our 
bis-peptide oligomers.  RDCs restrain the angle that C-H bonds can make relative to the direction 
of the external magnetic field and thus relate the orientation of distant parts of an oligomer to one 
another to gain global information on the structure. 
Residual dipolar couplings have been used extensively in the structural determination of 
proteins and recently have been employed in the structural assignment of small organic 
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molecules.38-41 This new tool can prove to be quite a powerful technique in determining 
conformations of the restrained bis-peptides synthesized in our group and will be used in 
conjunction with J-coupling values and ROESY constraints to determine the solution structure of 
scaffold 3.1. 
3.2 MODELING THE MONOMER CONFORMATIONS WITHIN 
OLIGOMER 3.1 
The molecular mechanics calculations performed on the sequence pip5(2S5R)-pip5(2R5S)-
pro4(2S4S)-(L)-tyrosine (Figure 10) predicts that the pipecolic acid monomer pip5(2S5R) (ring 
A) adopts the chair conformation placing C7 in the equatorial position thus avoiding unfavorable 
1,3 diaxial interactions (Figure 11 A).  The second pipecolic acid monomer pip5(2R5S) (ring C) 
is also predicted to adopt a chair conformation that places C11 in the equatorial position avoiding 
1,3 diaxial interactions (Figure 11 B).  The pro4(2S4S) (ring E) monomer is predicted to adopt 
an envelope conformation avoiding pseudo-1,3 diaxial interactions by placing C22 in the 
pseudo-equatorial position (Figure 12).  The DKP ring linkages ring B and ring D are predicted 
to adopt shallow boat conformations placing their exo-cyclic substituents C17 and C28 
respectively in the pseudo-equatorial positions. 
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Figure 10: Atom numbering and ring nomenclature of  3.1. 
 
 
 
 
 
 
 
 
Figure 11: Lowest energy predicted conformations for pip5(2S5R) (A) and pip5(2R5S) (B) 
residues within the context of the full oligomer structure. 
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Figure 12: Lowest energy predicted conformation for pro4(2S4S) residue within the context 
of the full oligomer structure. 
3.3 RESULTS 
3.3.1 13C, 1H Chemical Shift Assignment 
In-depth structural analysis of 3.1 was performed by 2D-NMR in order to verify the connectivity, 
to confirm the assigned stereochemical assignments, and to help determine the conformation of 
the molecule in solution.  The full structural assignment of 1H and 13C resonances of the hetero-
oligomer were completed by performing 1H, HMBC, and TOCSY NMR experiments on a 5 mM 
solution of 3.1 and HSQC-F1 dimension no decoupling and a ROESY NMR experiment on a 11 
mM solution of 3.1 in 90% H2O/D2O with 20 mM acetate buffer at pH 3.4.  This pH of 3.4 was 
used to slow the amide proton exchange as fast amide proton exchange with presaturation for 
solvent suppression will reduce signal intensity.  The assignment of oligomer 3.1 was carried out 
using the software package SPARKY. 
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3.3.2 Conformation Determination Using ROESY Cross-Peaks 
The ROESY spectrum provides cross peaks between protons that approach each other within 4Å.  
This close contact information was able to relate the amide hydrogens (HN10, HN21, HN31) 
with the methylene protons of the attached ring system allowing their diastereotopic assignment.  
In addition, ROESY cross-peaks observed for the three axial protons syn to each other on the 
two pipecolic acid rings A and C helped to confirm the chair conformation predicted by the 
Amer94 forcefield.37  The relative intensities of the ROESY cross-peaks between protons were 
assigned as strong, medium, and weak based upon the Gaussian integrated intensities and are 
shown in Figure 13 as colored lines that suggest degrees of close-contact between the protons. 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: The lowest energy conformation of 3.1 shown with observed ROESY 
correlations.  Correlated protons are connected by lines (strong – red, medium – green, 
weak – blue). 
 
 26 
On ring A, cross-peaks are observed between protons H2-H3α, H2-H4α, and H2-H6α.  In 
addition, cross-peak correlations are observed between H4α and H6α and between HN10-H6α 
and HN10-H4α.  This information helps confirm the stereochemical assignment of ring A as well 
as support the predicted chair conformation with N10 in the equatorial position of ring A.  On 
ring C, cross-peaks are seen between all pairs of protons H12, H17α, H18α, and H20α 
suggesting that they are on the same side of ring C.  Protons HN21, H18α and H20α also show 
cross-peak correlations consistent with the designed stereochemistry.  Once again, the observed 
correlations are in full agreement with the predicted chair conformation with N21 in the 
equatorial position of ring C.  On ring E, a medium cross-peak is observed between protons 
H30α and H28α and a medium cross peak between H23 and H30α suggesting that these protons 
are on the same side of the ring.  In addition, correlations can be seen between protons HN31-
H28β and HN31-H30β which is consistent with the designed stereochemistry 
ROESY cross-peaks were also observed between hydrogens on adjacent monomers 
which are consistent with the designed sequence of bis-peptide oligomer 3.1. A strong cross-
peak is observed between H23 and H18β, and a weak cross peak is observed between H6β and 
H17β.  These particular close-contact correlations help to confirm that the DKP rings B and D 
occupy shallow boat conformations placing C17 and C6 into pseudo-axial positions and H23 and 
C18 into pseudo-axial positions.  Lastly, ROESY cross-peaks between the protons on the 
aromatic side chain of the tyrosine and H30α suggests that the tyrosine folds back upon the 
oligomer as seen in previous studies.19,22  The solution structure determined by NMR is in 
agreement with the predicted lowest energy conformation of 3.1 from MOE.28 
Close contact information provided by ROESY cross-peak correlations provide insight 
into the molecular conformation of our bis-peptide oligomer.  However, this alone cannot 100% 
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confirm the exact molecular conformation of 3.1 because ROESY correlations represent the 
average conformation of 3.1 if conformational switching is faster than the NMR timescale.  
Therefore, I turned to 1H-1H J couplings and residual dipolar coupling to obtain more NMR 
restraints on structure 3.1. 
3.3.3 Using 1H-1H couplings to Restrain Ring Conformations 
1H-1H J couplings provide important dihedral information that can be of great value in structural 
determination by NMR42.  Compared to the process of measuring J-couplings from 1D 1H 
spectra, measuring J-couplings from 2D spectra is difficult.  Delaglio and co-workers have 
developed an effective method to obtain J-coupling information from cross peaks in phase-
sensitive COSY spectra by amplitude-constrained multiplet evaluation (ACME).42 As the 
acronym suggests, this method operates by constraining the multiplet intensities assuming full 
relaxation of spin systems.  Constraining the multiplet intensity for every set of cross-peaks 
eliminates several problems of multiplet extraction.  For example, the large linewidth of 2D 
spectra results in a larger antiphase separation of lower intensity for the cross peaks leading to 
measured splittings larger than the true value (Figure 14).42 
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Figure 14: Effects of large linewidths in 2D COSYs that results in measuring larger J-
couplings.  The inner curve is the sum of the two antiphase peaks. 
 
The amplitude value used to constrain all cross-peaks is determined by phasing the 
diagonal of the COSY spectrum to be absorptive, and then the intrinsic signal intensity is 
determined as the average intensity from the well resolved diagonal peaks.  The diagonal is then 
removed from the phased COSY spectrum, and the J-couplings are calculated for each multiplet 
cross peak by a fitting process.  The fitting process is completed by an iterative process of 
shifting and adding antiphase peaks constrained with the intrinsic signal intensity until the 
theoretical cross-peaks matches the original multiplet.  The J-coupling constant is then measured 
from the antiphase peaks used to generate the model. 
A phase-sensitive COSY with States acquisition mode (256 data points in F1 and 4K data 
points in the F2 dimension zero filed back to 4K for a resolution of 1.36 Hz/point) was acquired 
on a 7.0 mM solution of 3.1 in D2O with 40 mM phosphate buffer at pH 7.5.  Using ACME, the 
3JHH coupling constants of each observed multiplet were determined (Table 1).   
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The dihedral angles of the COSY correlated protons in the lowest energy conformation of 
3.1 (Figure 13) were measured in MOE28.  The Karplus relation (3JHH = 7 – cosθ + 5cos2θ) was 
then used to calculate theoretical 3JHH coupling constants from these measured dihedral angles.  
The experimentally measured J-couplings were consistent with predicted J-couplings (Table 1) 
providing evidence for the proposed energy minimized conformation of bis-peptide oligomer 
3.1.  Unfortunately, the 3JHH coupling could not be measured for all COSY interactions on the 
pip5(2S5R) and pip5(2R5S) rings due to overlap of the beta and gamma protons.  These cross-
peaks resided too close to the diagonal peaks and were lost during the absorptive diagonal 
subtraction of the phased COSY spectrum. 
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Table 1: Measured 3JHH coupling constants with ACME and calculated 3JHH values from 
lowest energy conformer of 3.1. 
 
The pip5(2S5R) residue (ring A) is not constrained by a DKP linkage on the resin bound 
terminus.  Thus ring A may be more conformationally mobile than the other rings in the bis-
peptide oligomer.  While ring A may be mobile, I set out to test the possibility of ring A 
possessing a well defined conformation.  In order to test this hypothesis, ring A of the oligomer 
was flipped into three other possible conformations designated Twist Boat 1, Chair 2, and Twist 
Boat 2.  These conformations were energy minimized with an Amber94 forcefield.37 The 
dihedral angle of each set of COSY correlated protons on ring A was measured in MOE28 for 
Resonance 
3JHH 
(measured) 
Measured 
Dihedral 
Angle 
3JHH 
(calculated)
Ring A    
H3β – H2 12.0 Hz 171.6 ° 12.8 Hz 
H3α – H2 4.4 Hz 54.0 ° 4.9 Hz 
H3β – H4α 11.4 Hz 166.1 ° 12.4 Hz 
H3α – H4α 6.9 Hz 48.6 ° 5.7 Hz 
Ring C    
H17β – H12 12.1 Hz 178.0  ° 13.0 Hz 
H17α – H12 3.4 Hz 59.3 ° 4.1 Hz 
Ring E    
H28β - H23 10.7 Hz 161.4 ° 11.9 Hz 
H28α – H23 7.1 Hz 39.9 ° 7.1 Hz 
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each new ring A conformation. The 3JHH values were calculated (3JHH = 7 – cosθ + 5cos2θ) for 
each conformation and compared to the ACME measured 3JHH coupling values (Table 2). 
 
Calculated 3JHH Resonance Measured  3JHH 
Twist Boat 1 Chair 2 Twist Boat 2 
H3β – H2 12.0 Hz 11.2 Hz 2.8 Hz 8.5 Hz 
H3α – H2 4.4 Hz 7.6 Hz 6.2 Hz 2.0 Hz 
H3β – H4α 11.4 Hz 13.0 Hz 4.2 Hz 4.8 Hz 
H3α – H4α 6.9 Hz 4.1 Hz 4.4 Hz 3.9 Hz 
Table 2: Measured 3JHH and calculated 3JHH for allowable conformations of ring A. 
It becomes evident that the only conformation of ring A that can coincide with the 
measured 3JHH coupling values is Twist Boat 1.  In order to further verify if this conformation of 
ring A is a conformational possibility, the conformation of Twist Boat 1 was overlaid with the 
observed ROESY correlations that are shown in Figure 15 as colored lines that suggest degrees 
of close-contact between the protons.  This new conformation of ring A does not support the 
strong ROESY correlations observed between H2 and H6α and between HN10 and H6α on ring 
A.  In addition, the inter-residue weak correlation between H6β on ring A and H17β on ring C is 
not consistent with this twist boat conformation.  This twist boat conformation of ring A would 
give rise to a ROESY cross-peak between H6α and H17β which I do not see in the 2D ROESY 
spectrum.  Information from the ROESY cross-peaks and the 3JHH coupling constants support the 
idea that ring A is not in a static conformation but is rather flipping between an ensemble of 
allowed conformations.  In order to help confirm this hypothesis, residual dipolar coupling was 
used to provide more insight into the conformational dynamics of bis-peptide oligomer 3.1. 
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Figure 15: Twist Boat 1 conformation of ring A (orange) in 3.1 shown with observed 
ROESY correlations.  Correlated protons are connected by lines (strong – red, medium – 
green, weak – green). 
3.3.4 Residual Dipolar Couplings to Restrain Ring Conformations 
Dipolar coupling is a through space interaction where the magnetic field of one nucleus, Q, 
effects the strength of the magnetic field of another nucleus, P.  The amount of change in the 
magnetic field strength felt by nucleus P depends on the internuclear distance between P and Q 
(Figure 16).43  This effect is dependent upon the magnetogyric ratios of the two nuclei (γP,γQ), 
the inverse cube of the distance between the nuclei (rPQ3), the magnitude of molecular alignment 
with the applied field B0 (AZZ), and the angle of the internuclear vector with respect to B0  
(Figure 17).43 
 
 
 
 
 
 
 33 
 
 
 
 
 
 
Figure 16 (adapted from ref 43): Magnetic dipole-dipole coupling of Q and P. 
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Figure 1743: (Eq 1) Describes the angular dependence of the internuclear vector on the 
magnitude of the dipolar coupling. (Fig 1) Shows the internuclear vector and its angle, θ, 
with the z axis, or B0. 
 
In solid state NMR, the dipolar couplings are very large interactions that give rise to very 
large splittings (on the order of 1000’s of Hz).  In contrast, when in solution the molecule rapidly 
rotates and the magnitude of the dipolar coupling averages exactly to zero.  Residual dipolar 
coupling is an “in-between” case where the molecule is partially oriented with respect to Bo by a 
liquid crystal ordering medium. 
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Figure 18: Representation of alignment tensor of solute molecule and a depiction of the 
internuclear vectors in orientation with applied magnetic field (B0). 
 
As briefly described above, RDCs contain information on the orientation of the 
internuclear vectors of the C-H bonds relative to the applied magnetic field.  In particular, the 
molecule possesses a certain alignment tensor (Figure 18) with the ordering medium, a vector 
which describes the likelihood of the molecule aligning with a principal axis (x, y or z) and 
relates the molecule to Bo.44  The alignment tensor represents one conformation of the solute 
molecule with respect to the applied magnetic field that is able to predict the experimentally 
measured RDCs.  For rigid molecules with relatively defined molecular shape, such as our rigid 
bis-peptide oligomers, where all bond orientations are restrained by the inherent conformation 
preferences of our monomers we can deduce an alignment tensor that correctly describes the 
experimentally measured RDCs.  Thus, residual dipolar couplings provide valuable restraints on 
internuclear vectors that can be used to relate the orientation of distant parts of the molecule 
relative to another allowing us to infer the global structure of the bis-peptide oligomer 3.1.   
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By introducing weak alignment of our solute molecule in an applied magnetic field, I was 
able to measure RDCs acquired in a C-H coupled HSQC spectra.  The alignment media chosen 
for the experiments was the filamentous bacteriophage, Pf1 phage45, obtained from Asla Biotech.  
When subjected to an applied magnetic field, the phage particles align with the sides of the NMR 
tube.  Steric and electrostatic interactions between the phage and the solute molecule give rise to 
the partial alignment of oligomer 3.1.   
Measuring the RDCs was accomplished by acquiring two C-H coupled HSQC spectra.  
The first was acquired (4k data points in the F1 dimension zero filed back to 4k and 4k data 
points in the F2 dimension) with no Pf1 phage present as to measure 1JCH coupling values with 
dipolar couplings averaging to zero, while the second was acquired (4k data points in the 
F1dimension zero filed back to 4k and 2k data points in the F2 dimension) with a 10 mg/mL 
concentration of phage to measure the 1JCH + 1DCH coupling values.   
These splittings can be measured in the higher resolution F2 dimension, but the alignment 
media causes significant line broadening leading to inaccuracy in locating the centers of the 
resonance peaks.  Therefore when acquiring the HSQC spectra the 180 ° pulse on the 1H channel 
during the t1 evolution period and decoupling during signal acquisition were eliminated.  This 
causes the splitting values of the 1H-13C residual dipolar coupling to occur in the F1 dimension.  
Measuring the splittings in the F1 dimension reduces the line broadening problem allowing for 
better precision in measuring the 1JCH and 1JCH + 1DCH values.   
The measured 1DCH values are recorded in Table 3.  When measuring the 1JCH and 1JCH + 
1DCH values for methylene units in the F1 dimension, it should be noted that the corresponding 
values represent the combined splitting (1JCH1 + 1JCH2+ 1DCH1 + 1DCH 2) for the geminal pair.  At 
first glance the RDCs seem very large on the order of 0 – 100 Hz (Table 3), but there was no 
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severe line broadening in the F1 dimension allowing for the precise determination of the middle 
of each resonance peak. 
A Residual Dipolar Coupling Analysis Tool (REDCAT)46 was used to evaluate the 
measured RDCs with respect to the energy minimized structure of 
bis-peptide oligomer 3.1.  The REDCAT program uses an input conformation and the measured 
RDC values to determine the best fit alignment tensor.  I then used this alignment tensor to 
predict theoretical RDC values for the input structure and to determine the RMSD between the 
predicted and experimentally measured RDCs.  
 
 
When the measured RDC values and the lowest energy conformer of 3.1 determined in 
vacuo using the Amber9437 forcefield were entered into REDCAT, the algorithm did not find 
solutions when attempting to determine the best fit alignment tensor.  However, when omitting 
the RDC values measured for the 1H-13C vectors on ring A and on the tyrosine residue, the 
REDCAT program was able to predict an RMSD value of 2.9 for the lowest energy conformer of 
Resonance ∑1DCH (Hz) Predicted 1DCH (Hz) 
H2-C2 8.64 NA 
H3α-C3 & H3β-C3 65.82 NA 
H6α-C6 & H6β-C6 -40.04 NA 
H12-C12 46.89 43.40 
H17α-C17 & H17β-C17 65.82 68.68 
H18α-C18 & H18β-C18 -5.66 -4.68 
H20α-C20 & H20β-C20 64.07 70.07 
H23-C23 -17.76 -17.68 
H28α-C28 & H28β-C28 -113.15 -111.74 
H30α-C30 & H30β-C30 -3.25 -3.04 
H33-C33 -36.18 -36.84 
2(H37-C37) 24.66 25.52 
Table 3: Comparison of measured and calculated RDCs from best fit alignment tensor. 
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3.1 (Figure 19).  As mentioned previously, it is possible for ring A to be conformationally mobile 
due to the lack of a second DKP linkage on the resin bound terminus.  This suggests why the 
REDCAT algorithm breaks down when the RDCs from ring A are incorporated in the best 
alignment tensor fitting process.  As a result these RDCs as well as the RDCs from the tyrosine 
residue were omitted during initial REDCAT analysis.   
I found one conformation of rings C, D, and E that provide a good fit with the measured 
RDCs.  In order to further reduce the RMSD fit for the backbone of ring C, ring D, and ring E, a 
dynamic search of ring B and ring A was conducted while fixing the rest of the molecule 
creating conformers with slightly varied H12–C12 vectors (Figure 19).  This bond is part of the 
DKP linkage connecting ring A and ring C and its orientation will depend upon the conformation 
of ring B which is directly coupled to the conformation of ring A.  The best fit structure 3.3 
provided an RMSD of 2.4 (Figure 19).   
 
Figure 19: Rings C, D, E, F, and the tyrosine residue were held fixed in space while a 
molecular dynamic search was carried out on rings A and B.  This refined the positioning 
of the H12-C12 vector leading to a lower RMSD value of 2.4. 
 
To this point, the RDCs from the tyrosine residue have not been incorporated into the 
best alignment tensor RMSD fit.  When including the H33-C33 RDC value with the best fit 
3.33.2
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structure 3.3 (Figure 19) in REDCAT46, the RMSD value jumps to 11.4.  In order to attain a 
better fit, a dynamic search of the tyrosine residue was carried out while holding the rest of the 
molecule rigid yielding best fit structure 3.4 with an RMSD of 2.2 (Figure 20).  When including 
the combined H37-C37 RDC values with this new best fit structure 3.4, the RMSD value jumps 
to 6.1.  The H37-C37 bonds at the beta position of the tyrosine residue are free to rotate about 
the C33-C37 and C37-C39 bonds.   In order to further reduce the RMSD best fit, both these C33-
C37 and C37-C39 bonds were rotated at 5° increments.  The RMSD value decreased to 2.2 with 
best fit structure 3.5 (Figure 20).   
 
Figure 20: The refinement process of finding the tyrosine conformation with the best 
RMSD fit.  First a dynamic search was done on the tyrosine residue followed by allowing 
C33-C37 and C37-C39 to search their conformational space. 
 
The alignment tensor provided by the refined structure of 3.1 was used to predict 
theoretical RDCs (Table 3) for the inputted C-H bonds.  It can be seen that these values are very 
consistent with the observed measured RDC values.  A correlation plot between these predicted 
RDCs and experimentally measured RDCs is shown in Figure 21.   
This refined structure of 3.1 treats the tyrosine residue as a static appendage, but it is 
possible for this terminal residue to rotate about the C33-C37 and C37-C39 bonds as well as 
there to be breathing motions of the DKP linkage (ring F) that connects this residue.  The RMSD 
3.3 3.4 3.5
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best fit structure of 2.2 represents the tyrosine conformation that best represents the measured 
RDC values.  However, close contact data from the 2D-ROESY spectrum is consistent with a 
conformation of the tyrosine residue that places it closer to H30α and H30β of ring E. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Correlation plot of experimentally measured RDCs vs. REDCAT46 calculated 
RDCs. 
 
In order to further demonstrate the utility of residual dipolar coupling in the structural 
determination and refinement of oligomer 3.1, I systematically flipped the backbone rings of the 
scaffold into higher energy conformers.  Ring C was flipped into its two boat conformations and 
the higher energy chair conformation, and ring E was flipped into its second envelope 
conformation.  These new conformations of 3.1 were used to generate predicted RDCs with 
REDCAT that were compared to the experimental RDCs in the RMSD sense.  It can be seen in 
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Table 4 that these other conformations do not fit well with the experimentally measured RDCs 
affording high RMSD values.   
 
Conformation of 3.1 RMSD Value 
3.5 (REDCAT refined conformation) 2.2 
3.6 (Ring C Boat 1) 16.4 
3.7 (Ring C Boat 2) 16.8 
3.8 (Ring E Envelope 2) 17.5 
3.9 (Ring C Chair 2) 23.0 
 
Table 4: RMSD values acquired from the higher energy conformations of scaffold 3.1 during 
REDCAT analysis. 
 
3.4 CONCLUSIONS 
This final refined structure of bis-peptide oligomer 3.1 comprised of rings C, D, E, F, and the 
tyrosine residue has provided an RMSD value of 2.2 from REDCAT analysis and is in full 
agreement with the close contact information from the 2D-ROESY spectrum as well as the 
experimentally measured 3JHH coupling values.  To conclude, I have confirmed that the backbone 
of 3.1 is structurally rigid and incapable of ring flipping.  However, the beginning pip5(2S5R) 
residue, ring A,  does not possess a DKP linkage on the resin bound terminus.  There is no 
evidence by our analysis for a single conformation of ring A.   
I have shown that there is a single conformation for rings C, D, E, F, and the tyrosine 
residue that is in agreement with ROESY cross-peak correlations, 3JHH coupling constants, and 
measured RDC values.  This backbone does create a turn.  In addition, I have shown that the 
amplitude constrained multiplet extraction42 of 3JHH coupling constants provides important 
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dihedral angle information of our bis-peptide oligomers.  Also, residual dipolar coupling has 
proven to be a great complimentary NMR technique to use for our bis-peptide structural 
determinations, and it is able to determine if a certain ring in our bis-peptide oligomers is 
conformationally mobile. 
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4.0  INITIAL DEVELOPMENT OF AN ACTUATED GLUCOSE 
SENSOR 
4.1 INTRODUCTION AND BACKGROUND 
Over the last decade, there has been an increasing interest in developing glucose sensors.47-51  
For the development of continuous in vivo glucose monitoring systems, implantable chemical 
glucose sensors52-56 need to be in continuous contact with biological fluid in the human body so 
as to provide a constant measure of glucose levels in the body allowing the achievement of tight 
diabetes control.  The idea of tight control is to maintain blood glucose levels as close to normal 
as possible so as to prevent or slow the progress of many complications that are characteristic of 
diabetes.  These complications can include eye disease, kidney disease, and nerve disease. 
Unfortunately, the use of glucose oxidase based sensors for glucose detection suffers 
problems of prolonged stability as well as the need for constant recalibration.  Therefore, much 
effort has been devoted to synthesizing chemical glucose sensors.48,49,51,57,58  In order to complete 
the task of creating an efficient chemical glucose sensor, a functional group that interacts with 
glucose needs to be identified as well as the appropriate construction of a three-dimensional 
scaffold structure.49  Boronic acids are capable of binding diols at neutral pH (Figure 22) and 
have served the purpose of binding to saccharides very well, and have been used to create many 
examples diboronic acid sensors.48,49,51,57-59   
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Figure 22: Binding between a phenylboronic acid and diol. 
 
Typical glucose levels in the body range from 4 – 8 mM.  Patients with diabetes attempt 
to maintain glucose levels within this range.  Therefore, developing a glucose sensor that has a 
dissociation binding constant within this range would produce a sensor that is most responsive 
between the 1 -10 mM glucose range.  Phenylboronic acids typically possess a Kd around 100 
mM.  Therefore, a designed chemical glucose sensor would need to show around a 20 fold 
increase in binding affinity for glucose in order to possess the sensitivity needed for detecting 
glucose levels in the 1 – 10 mM range. 
Diboronic acid sensors have the ability to simultaneously bind to the 4,6 and 1,2 diol 
pairs on glucose.  It has been investigated and determined that for the binding of glucose with 
these bis-boronic acid sensors there is a strong thermodynamic preference for the α-D-
glucofuranose form51 over the α-D-glucopyranose form (Figure 23).  Upon binding to a boronic 
acid the pyranose form undergoes mutarotation to the furanose form relatively quickly in 
aqueous conditions.   
 
 
 
  
Figure 23: Boronic acid complexes of α-D-glucopyranose and α-D-glucofuranose 
respectively. 
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Of the vast array of small molecule based glucose sensors, most appear to be only water 
soluble after the addition of the sugar to the sensor itself.  A powerful aspect of our synthetic 
approach is that we can independently adjust the water solubility of our glucose sensor without 
altering the other properties of the sensor.  I have been focusing on creating an actuated water 
soluble-diboronic acid glucose sensor comprised of a rod-hinge-rod structure that converts from 
its disordered “open” form to an ordered “closed” form upon reversible binding to glucose 
(Figure 24).  By placing “payloads” on each end of the hinged molecule, I can monitor the 
actuation (transition between the “open” and “closed” states) upon the addition of glucose so as 
to measure binding isotherms. 
The “payloads” that can be used for our purposes can consist of a number of possibilities 
which includes a pair of fluorophores for fluorescence resonance energy transfer (FRET), 
excimers such as pyrene moieties, or even the possibility of anchoring one end of the glucose 
actuator to a single wall carbon nanotube with a charge on the other end so as to control the flow 
of current through the nanotube. 
 
 
Figure 24: A schematic diagram of the molecular actuator glucose binding event. 
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There are many possibilities for the construction of this glucose sensor that is comprised 
of the rod-hinge-rod motif.  For example, by controlling the overall structure and number of 
rotatable bonds within the hinge or by decreasing or increasing the number of bis-amino acid 
monomers in the rods I may be able to tune the degree of binding of the molecular actuator with 
glucose.  In addition, changing the bis-amino acid monomers to different stereoisomers may also 
lead to changes in the glucose binding affinity.  The studies provided to date demonstrate the 
initial development of this technology, and it must be stressed that many variants of the rod-
hinge-rod system that consist of these variable hinge lengths, rod lengths, and monomer 
stereoisomers will be synthesized and studied.  
 
 
Figure 25: Molecular valves formed by attaching glucose sensitive molecular actuators to 
the insides of ~ 10 nanometer diameter alumina channels. At low glucose (yellow) 
concentrations the actuators will be disordered and block the channel (“valveclosed” state).  
In the presence of high glucose concentrations, the actuators will fold back, creating a 
channel with a diameter of about 5 nanometers, large enough to allow small proteins such 
as insulin to pass through (“valve-open” state).  
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It is an eventual goal of this project to someday create a working nanochannel based 
valve (Figure 25) by incorporating these actuating glucose sensors into alumina nanopore 
membranes.  The opening and closing of these valves achieved by molecular actuation via 
reversible glucose binding will be able to control the flow of insulin and is dependent upon the 
overall glucose concentration present. 
4.2 GLUCOSE SENSOR DESIGN AND SYNTHESIS 
The first hinged molecule designed for these studies is composed of a rod-hinge-rod motif 
constructed from our bis-amino acids with an ornithine as the hinge (Figure 26).  The rod 
segments of the molecule are each comprised of 4 pro4(2R4R) monomers that are connected by 
an ornithine hinge.  The choice of “payloads” selected to actively monitor the glucose binding 
event are the naphthyl and dansyl fluorophore pair for monitoring with FRET.  FRET is an 
energy transfer phenomenon that has been used extensively to measure distances and monitor 
structural changes in proteins and peptide sequences.60-63  
One end of the actuator contains the dansyl fluorophore and one boronic acid as the other 
end has the naphthyl fluorophore and the second boronic acid.  I set to determine the distance 
between the two fluorophores when in the disordered “open” state (~20-50 Å) and the distance 
between the fluorophore pairs when in the ordered “closed” state (~15-25 Å).  I chose the 
naphthyl/dansyl pair because its Förster distance is ~22 Å which is the separation distance 
between the two fluorophores that yields 50% FRET efficiency.  The FRET phenomenon works 
by exciting the naphthyl group which then emits energy by dipole-dipole resonance to the dansyl 
group that then emits energy at a longer wavelength of 520 nm.   Upon titration of glucose, the 
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molecular actuator will bind to glucose in a 1:1 complex bringing the two fluorophores within a 
shorter distance.  As the glucose concentration increases, all actuator molecules in solution bind 
to glucose.  By measuring the efficiency of the fluorescence resonance energy transfer, I will 
generate binding isotherms that eventually will saturate at high glucose concentrations allowing 
the determination of binding constants.  
 
 
 
 
 
 
 
 
 
Figure 26: The molecular actuator structure of the diboronic acid glucose sensor. 
 
Molecular modeling suggests that the glucose bound-closed actuator molecule positions 
the two fluorophores between 15-25 A° apart, and the unbound-open form places the 
fluorophores anywhere between 20-50 A° apart.  I am hopeful for a large enough distance 
change that can be observed when monitoring the binding process between the actuated glucose 
sensor and glucose. 
Choosing a boronic acid that will bind strongly at neutral pH is dependent upon the pKa 
of the boronic acid.  In most but not all circumstances, the optimal pH at which the boronic acid 
will bind to diols is above the pKa of the boronic acid.64 Therefore, introducing electron 
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withdrawing groups on the aryl ring in the ortho- or para- positions should stabilize the boronate 
form lowering the pKa of phenylboronic acid (pKa=8.8).64,65  The phenyl boronic acid chosen for 
this study is 3-carboxy-2-fluorophenylboronic acid. 
In addition, boronic acids are susceptible to boroxine formation (Figure 27) in organic 
solvents rendering them hard to work with.66  To counteract this potential problem, boronic acids 
are protected with diols such as pinacol or neopentyl glycol.  Hoeg-Jensen has developed solid-
phase deprotection conditions for the pinacol boronate with N-methyldiethanolamine and 2M 
HCl67, and hence this strategy was employed in my synthetic scheme.  
   
  
  
  
 
Figure 27: Formation of boroxine with boronic acids. 
 
The 3-carboxy-2-fluorophenylboronic acid was protected as the pinacol boronate by 
treating it with pinacol in a mixture of 1:1 toluene/THF and evaporating to dryness under 
reduced pressure (Scheme 8) to yield 4.1.  The pinacol protecting group can then be 
subsequently cleaved via the two step treatment with 10% N-methyldiethanolamine/DMF and 
10% 2M HCl/DMF.67   
 
 
  
Scheme 8: Formation of pinacol boronate 4.1. 
 
B
OH
OH
B
O
O
B
B
O
3H2O
B
OH
OHF
HO2C 1:1 toluene/THF
pinacol
B
O
OF
HO2C
4.1
 49 
The scaffold was conveniently synthesized (Scheme 9) on the Dansyl NovaTag resin 
(Figure 28) installing the dansyl fluorophore on one end (C-terminus) of the molecular actuator.  
Upon cleavage of the linker with TFA, the C-terminus of the oligomer remains connected to the 
dansyl sulfonamide through a short linker (Figure 27).                           
 
 
 
 
 
 
 
 
 
 
 
Figure 28: Dansyl NovaTag resin. 
 
Scheme 9 shows the construction of the actuated glucose sensor, 4.3. Initially a N-α-
Fmoc-N-γ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-diaminobutanoic acid 
(Fmoc-Dab(ivDde)-OH) was coupled to resin followed by the sequential coupling of 4 Boc-
pro4(2R4R) monomers.  The flexible hinge was next installed as a N-α-Fmoc-N-δ-4-
methyltrityl-L-ornithine (Fmoc-Orn(Mtt)-OH).  The Fmoc protection in 20% piperidine/DMF 
was carried out for 2 hours to ensure a complete DKP closure between the ornithine and C-
terminus connected Boc-pro4(2R4R) monomer. The side chain Mtt protecting group was 
subsequently removed with 1% TFA in DCM.  To this free amine was coupled a Boc-
pro4(2R4R) monomer followed by the sequential coupling of 3 additional Boc-pro4(2R4R) 
monomers.  To the terminal Boc-pro4(2R4R) monomer was coupled a N-α-Fmoc-N-ε-4-
methyltrityl-L-diaminoproprionic acid (Fmoc-Dpr(Mtt)-OH) followed by a 2 hours Fmoc 
deprotection in 20% piperidine/DMF to ensure a complete DKP closure between the Dpr(Mtt) 
N
H
O
O
OMe
N
SO2
N
H
Fmoc
N
 50 
residue and C-terminus connected pro4(2R4R) monomer.  The side chain Mtt protecting group 
was subsequently removed with 1% TFA in DCM and to this free amine was coupled an Fmoc-
(S)-naphthylalanine installing the napthyl fluorophore on the end of the scaffold.   
In order to simultaneously couple both 3-carboxy-2-fluorophenyl pinacol boronates to the 
oligomer, the ivDde side chain protecting group on the beginning Dab residue was removed with 
treatment to 1:4.5:4 hydrazine/All-OH/DMF yielding intermediate 4.2.  Next the pinacol 
boronate (4.1) of 3-carboxy-2-fluorophenylboronic acid was coupled to both free amines on the 
scaffold.  The pinacol protecting groups of both boronic acids were then subsequently cleaved 
via the two step treatment with 10% N-methyldiethanolamine/DMF and 10% 2M HCl/DMF.67  
The assembled scaffold was cleaved from the resin linker of the Dansyl NovaTag resin 
with 95% TFA, 2.5% H2O, 2.5% TIPS to yield the globally Boc-deprotected scaffold.  All 
diketopiperazines were closed in 20% piperidine in NMP and was completed after 1 day.  The 
final closed product was precipitated in anhydrous ether and reverse phase purified by RP-HPLC 
on a 0-50 % gradient of MeCN/H2O over 30 minutes to yield pure 4.3 (Figure 29).   
 
 
 
 
 
 51 
 
Scheme 9: Synthesis of the molecular actuator glucose sensor 4.3. 
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Figure 29: HPLC-MS: column, Waters XTerra MS C18 column; mobile phase , 
MeCN/water (0.1% formic acid), 5% to 95% MeCN over 30 minutes; flow rate, 0.4 
mL/min; UV detection at 274 nm; tR 11.554 min; ES-MS m/z (ion) 1114.5 (M+2H+); m/z 
ion 743.5 (M+3H+). 
4.3 TITRATING THE HINGED BIS-BORONIC ACID ACTUATOR 
WITH GLUCOSE 
The molecularly actuated glucose sensor contains a donor napthyl group and an acceptor dansyl 
group separated on the two ends of the molecule.  Glucose is known to bind dibornic acceptors 
via the 4,6 and 1,2 diol pairs, and thus the actuator should close upon binding to glucose in a 1:1 
complex bringing the spatial orientation of the two fluorophores closer together inside the 
Förster distance of 22 Å.  In order to observe this, excitation spectra were collected during the 
addition of D-glucose from 0-90 mM to a 10 μM solution of 4.3 in 0.1 M phosphate buffer at pH 
7.4.  The increase in fluorescence intensity can be observed in Figure 30 showing a relatively 
small increase in intensity changes.  The Kd was approximated to be ~8 mM, a five fold increase 
from the monovalent Kd of 40 mM (Figure 31). 
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Figure 30: Excitation spectra of 4.3 (10 μM) upon addition of D-glucose (0-90 mM) at 25 °C 
in 0.1 M phosphate buffer at pH 7.4; λem = 520 nm. The spectra are normalized at 100 
units at 337 nm. 
 
 
Figure 31: (RED) Fluorescence intensity changes as a function of glucose concentrations of 
4.3 at 25 °C; 10 μM in 0.1 M phosphate buffer at pH 7.4; λex = 293 nm, λem = 520 nm. 
(Green) Integral ratio changes as a function of glucose concentration of monovalent 
boronic acid in 0.1 M phosphate at pH 7.4. 
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The fluorescence intensity changes are small (Figure 31) and can be rationalized when 
considering the number of possible conformations of the disordered “open” state of the glucose 
sensor.  It is possible that instead of the rod-hinge-rod motif being more extended, that the 
disordered “open” form actuator holds the naphthyl and dansyl groups closer in proximity thus 
achieving a smaller change in separation upon converting to the ordered “closed” state when 
bound to glucose.  As seen in Figure 32, there are many conformations available to the hinged 
molecule when the two rods are close to 90° to each other.  The average distance between the 
two fluorophores was found to be 33 Å.  This would apply a relatively small change in distance 
between the disordered and ordered states, and would account for the small increase in 
fluorescence intensity. 
Figure 32: The overlaid structures of the available conformations of the disordered “open” 
hinged molecule 4.3.  The average distance between the dansyl/naphthyl fluorophores is 
33Å. 
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An ideal sensor would display a large change in fluorescence intensity when going from 
the unbound state to the bound state.  In order to achieve this goal, the inherent design of the 
actuator can be altered by decreasing or increasing the length of the rods or by changing the 
flexibility of the hinge.  Increasing the length of the rods would cause the fluorophores to have a 
larger distance separation when in the disordered unbound state possibly leading to larger 
distance changes between the bound and unbound states. 
In addition to changing the structure of the sensor to achieve better sensitivity, I can also 
change the pair of fluorophores used for the FRET studies.  The dansyl/naphthyl pair was 
synthetically convenient but a poor choice from the point of view of maximizing signal.  Since it 
is easy to change the fluorophores, other signaling groups such as pyrenes for excimer formation 
will be explored as a potential signaling system.  In addition to searching for different signaling 
groups, we will also explore different hinges with different molecular rod structures in order to 
improve signal.  Currently the glucose actuated hinged molecule has a dissociation constant 
within the physiological range of glucose concentrations.  I hope to create a few more hinged 
glucose sensors that are within the same physiological range. 
 This glucose molecular actuator opens the doorway for many important applications in 
the field of continuous glucose monitoring as well as in developing nanochannel based valves.  
Current studies are underway in attempting to create hinged sensors with increased signal 
between disordered “open” and ordered “closed” states.  These studies will hopefully lead to 
improved glucose controlled molecular actuators. 
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5.0  EXPERIMENTAL SECTION 
5.1 CHAPTER 2 
General: CH2Cl2 was distilled from CaH2 under N2, and THF was distilled from 
Na/benzophenone under N2.  All other reagents were used as received from the company unless 
stated otherwise.  All reactions were carried out in oven-dried glassware under an atmosphere of 
N2 unless noted differently.  Column chromatography was performed with ICN Silitech 32-63 D 
(60 A) grade silica gel using Redisep normal phase chromatography silica-gel columns on a 
Combiflash companion purification system from ISCO Inc.  Analysis by TLC was carried out on 
EM Science Silica Gel 60 F254 plates with a 250 μm thickness.  NMR experiments were 
performed on Bruker Advance 300 MHz, Bruker Advance DRX 500 MHz, or Bruker Advance 
DRX 600 Mhz spectrometers.  All chemical shifts are reported relative to CDCl3, DMSO-d6, 
AcOD-d4, or MeOD residual solvent peaks.  When possible, rotational isomers were resolved by 
performing 1H NMR experiments at 350 K in DMSO-d6.  IR spectra were obtained on a Nicolet 
Avatar E.S.P. 360 FT-IR.  Optical rotations were obtained on a Perkin-Elmer 241 polarimeter.  
High resolution ESI-MS was performed on a Waters LC/Q-TOF instrument.  HPLC-MS analysis 
was performed on a Hewlett-Packard Series 1050 instrument with a diode array detector, HP 
1100 MS detector (ESI), using a Waters Xterra MS C18 column (3.5 μm packing, 4.6 X 100 
mm).  Purification by preparative HPLC was performed on a Varian Prostar 500 HPLC system 
with a Waters Xterra MS C18 column (5 μm packing, 30 X 100 mm) or a Waters Xterra MS C18 
 57 
column (5 μm packing, 10 x 100 mm).  Analysis of 2D NMR data was performed using Sparky 
3, T. D. Goddard and D.G. Kneller, University of California, San Francisco.  
 
The following procedures parallel those in the synthesis of the pip5(2S5S) and the 
pro4(2S4S) (TFP ester version) bis-amino acid monomers23, 25. 
 
 
 
 
 
 
 
(R)-5-oxopiperidine-1,2,4-tricarboxylic acid 1-benzyl ester 2-tert-butyl ester 4-ethyl ester 
(2.3) and (R)-4-oxopiperidine-1,2,5-tricarboxylic acid 1-benzyl ester 2-tert-butyl ester 5-
ethyl ester (2.4) 
Compound 2.2, (R)-4-oxopyrrolidine-1,2-dicarboxylic acid 1-benzyl ester 2-tert-butyl ester, 
(17.0 g, 53.3 mmol) was transferred to a 1000 ml round bottom flask containing a magnetic stir 
bar and fitted with a rubber septum.  The flask was purged with nitrogen, and compound 2.2 was 
dissolved in anhydrous Et2O (426 mL).  The solution was cooled to 0 °C using an ice bath.  The 
rubber septum was punctured with a 21G2 precision glide needle to allow venting for the 
remainder of the procedure.  Boron trifluoride (13.5 mL, 106.7 mmol) was added dropwise via a 
continuous flow injector over a 30 minute period and then allowed to stir for 10 minutes.  Ethyl 
diazoacetate (6.6 mL, 64.0 mmol) was added dropwise via a continuous flow injector over a 30 
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minute period.  The solution was stirred for 2 hours at 0 °C and subsequently for 2 hours at room 
temperature.  Saturated NaHCO3 solution (250 mL) was slowly added to the solution and 
allowed to stir for 20 minutes.  The resulting solution was transferred to a 2 L separatory funnel 
and was diluted with EtOAc (400 mL).  The organic layer was separated and washed with 
saturated NaHCO3 (3 x 250 mL) and then washed with brine (3 x 200 mL).  The EtOAc layer 
was then dried over anhydrous MgSO4, and filtered.  The solution was concentrated by rotary 
evaporation and subsequently adsorbed onto celite.  This was followed by purification with flash 
chromatography on a Combiflash companion purification system (140g silica column, 5-30% 
EtOAc/Hexanes gradient).  Pure fractions were combined, and the solvent removed by rotary 
evaporation and under reduced pressure overnight.  The resulting oil (12.8 g, 59% yield) was 
carried on directly to the next reaction. 
 
 
 
 
(R)-5-oxopiperidine-1,2-dicarboxylic acid 1-benzyl ester 2-tert-butyl ester (2.5) and (R)-4-
oxopiperidine-1,2-dicarboxylic acid 1-benzyl ester 2-tert-butyl ester (2.6) 
The mixture of 2.3 and 2.4 (25.1 g, 61.8 mmol) was dissolved in DMSO (185.3 mL) and 
transferred to a 500 mL round bottom flask containing a magnetic stir bar.  H2O (2.2 mL, 123.6 
mmol) and NaCl (7.2 g, 123.6 mmol) were added.  The flask was fitted with a reflux condenser 
and allowed to reflux at 150 °C for 4 hours.  The solution was allowed to cool to room 
temperature and transferred to a 2 L separatory funnel and diluted with EtOAc (700 mL) and 
H2O (150 mL).  The EtOAc was separated, and the acqueous layer backwashed with EtOAc (2 x 
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200 mL).  The EtOAc layers were combined and dried over anhydrous MgSO4, and filtered.  The 
solution was concentrated by rotary evaporation and subsequently adsorbed onto celite.  This 
was followed with purification by flash chromatography on a Combiflash companion 
purification system (140g silica column, 5-30% EtOAc/Hexanes gradient, multiple columns were 
used).  Fractions with the pure products (2.5 or 2.6) were combined separately, and the solvent 
was removed on the rotary evaporator and under reduced pressure overnight yielding 2.5 as an 
oil (6.0 g, 23.6% yield) and 2.6 as an oil (3.4 g, 13.6 % yield). 
Characterization of 2.5. 
[α]23D = 5.8° (c 1.0, CHCl3); IR (film) νmax 2977, 1734, 1418, 1368, 1319, 1223, 1154, 1113, 
1051, 963, 846, 746, 698; 1H NMR (300 MHz, 77 °C, DMSO-d6) δ 7.50-7.54 (m, 5H), δ 5.24-
5.33 (br s, 2H), δ 4.75 (t, 6 Hz, 1H), δ 4.37 (d, 18.3 Hz, 1H), δ 4.06 (d, 18.3 Hz, 1H), δ 2.59-2.70 
(m, 1H), δ 2.47-2.55 (m, 1H), δ 2.40-2.43 (m, 1H), δ 2.24-2.30 (m, 1H), δ 1.56 (br s, 9H); 13C 
NMR (75.4 MHz, 20 °C, DMSO-d6) δ 205.7, δ 171.1, δ 155.2, δ 136.8, δ 128.4, δ 81.8, δ 67.3, δ 
54.8, δ 51.8, δ 35.7, δ 27.9, δ 23.2; HRMS-ES (m/z): 333.1592 (C18H23NO5 + Na+ requires 
333.1576). 
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(5R,8R)-2,4Dioxo-1,3,7-triazaspiro[4.5]decane-7,8-dicarboxylic acid 7-benzyl ester 8-tert-
butyl ester (2.7) and (5R,8S)-2,4Dioxo-1,3,7-triazaspiro[4.5]decane-7,8-dicarboxylic acid 7-
benzyl ester 8-tert-butyl ester (2.8) 
To a 350 mL pressure vessel containing a magnetic stir bar, ammonium carbonate (6.4 g, 66.6 
mmol), potassium cyanide (1.5 g, 23.4 mmol), and deionized water (65 mL) were added.  To this 
was added a solution of 2.5 (6.0 g, 18 mmol) in DMF (65 mL). The pressure vessel was sealed, 
and the reaction mixture stirred vigorously at 60 °C for 4 hours.  The pressure vessel was cooled 
to 0 °C with an ice bath, and was opened cautiously.  The solution was transferred to a 1000 mL 
Erlenmeyer flask and was acidified with 1 M HCl very slowly while stirring until no more 
bubbling occurred. The solution and precipitate were transferred to a 1000 mL separatory funnel 
and extracted with EtOAc (500 mL).  The aqueous layer was extracted with EtOAc (3 x 200 
mL).  All organic layers were combined and washed with brine (3 x 200 mL), dried over 
anhydrous MgSO4, and the solvent removed on the rotary evaporator and under reduced pressure 
overnight yielding a mixture of 2.7 and 2.8 in a ratio of 3:2 (determined by 1H NMR in DMSO).  
This mixture is not separable by flash chromatography and is carried through directly to the next 
step. 
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(5R,8R)-2,4-Dioxo-1,3,7-triazaspiro[4.5]decane-1,3,7,8-tetracarboxylic acid 7-benzyl ester 
1,3,8-tri-tert-butyl ester (2.9) and (5R,8S)-2,4-Dioxo-1,3,7-triazaspiro[4.5]decane-1,3,7,8-
tetracarboxylic acid 7-benzyl ester 1,3,8-tri-tert-butyl ester (2.10) 
The crude mixture of 2.7 and 2.8 (7..3 g, 18.00 mmol, assuming 100% yield) was dissolved in 
dry THF (325 mL) and transferred to a 500 mL round bottom flask containing a magnetic stir 
bar.  Di-tert-butyl dicarbonate (14.2 g, 65.22 mmol) and DMAP (.13 g, 1.1 mmol) were added.  
The reaction mixture was allowed to stir for 2 hours under N2 flow.  The solution was 
concentrated on a rotary evaporator and subsequently adsorbed onto celite.  This was followed 
with immediate purification by flash chromatography on a Combiflash companion purification 
system (140g silica column, 5-30% EtOAc/Hexanes gradient).  Fractions with pure products (2.9 
or 2.10) were combined separately and concentrated on a rotary evaporator at room temperature.  
In vacuo drying yielded 2.9 as a white foamy solid (4.00 g, 36.8 % yield based on 2.5 over 2 
steps) and 2.10 as a white foamy solid (1.64 g, 15.1 % yield based on 2.5 over 2 steps), as well as 
a mixture of 2.9 and 2.10 as a foamy solid (1.21g) 
 
Less Polar 2.9: 
[α]23D = -5.0° (c 1.0, CHCl3); IR (film) νmax 2981, 1825, 1782, 1731, 1423, 1370, 1307, 1252, 
1147, 976, 843, 756, 698; 1H NMR ((300 MHz, 20 °C, DMSO-d6) δ 7.30-7.33 (m, 5H), δ 4.27-
4.34 (m, 2H), δ 4.27 & 4.24 (rotamers, 1H), δ 3.91-4.12 (rotamers, 1H), δ 3.65 & 3.42 (rotamers, 
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1H), δ 2.10-2.17 (m, 2H), δ 2.01-2.07 (m, 2H), δ 1.49-1.52 (m, 27H); 13C NMR (75.4 MHz, 20 
°C, CDCl3) δ 170.0, δ 169.8, δ 168.0, δ 167.9, δ 155.7, δ 155.6, δ 148.6, δ 148.5, δ 147.2, δ 
147.1, δ 145.1, δ 136.5, δ 136.3, δ 128.6, δ 128.5, δ 128.2, δ 128.0, δ 127.8, δ 86.9, δ 85.5, δ 
82.3, δ 67.9, δ 67.7, δ 60.6, δ 60.6, δ 54.1, δ 53.6, δ 43.1, δ 42.7, δ 28.0, δ, 27.8, δ 25.9, δ 22.4, δ 
22.1; HRMS-ES (m/z): 626.2693 (C30H41N3O10 + Na+ requires 626.2690). 
More polar 2.10. 
[α]23D = 20.2° (c 1.0, CHCl3); IR (film) νmax 2980, 1827, 1786, 1740, 1456, 1423, 1369, 1318, 
1254, 1142, 1089, 1057, 842, 754; 1H NMR (300 MHz, 20 °C, DMSO-d6) δ 7.29-7.39 (m, 5H), 
δ 4.91-5.18 (m, 2H), δ 4.43 (t, 8.7 Hz, 1H), δ 4.22 (rotamers, 1H), δ 3.50 (rotamers 2d, 9.3 Hz, 
1H), δ 2.04-2.26 (m, 3H) δ 1.87 (m, 1H) δ 1.29-1.51 (m, 27H); 13C NMR (75.4 MHz, 20 °C, 
CDCl3) δ 171.0, δ 170.6, δ 169.8, δ 169.5, δ 155.5, δ 155.4, δ 148.6, δ 148.5, δ 147.0, δ 145.0, δ 
136.5, δ 136.3, δ 128.6, δ 128.5, δ 128.2, δ 128.0, δ 127.8, δ 87.1, δ 85.3, δ 81.8, δ 67.7, δ 67.4, δ 
63.9, δ 63.8, δ 55.3, δ 55.0, δ 47.1, δ 46.8, δ 28.1, δ 28.0, δ 27.8, δ 27.7, δ 22.3, δ 21.6; HRMS-
ES (m/z): 626.2676 (C30H41N3O10 + Na+ requires 626.2690). 
 
 
 
 
 
 
(5R,8R)-2,4-Dioxo-1,3,7-triazaspiro[4.5]decane-7,8-dicarboxylic acid 7-benzyl ester  (2.11) 
Compound 2.9 (52 mg, 0.086 mmol) was dissolved in a mixture of 3:7 TFA/DCM (~3.5 mL, 40 
mL per mmol of 2.9) and was transferred to a 25 mL round bottom flask fitted with a stir bar.  
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The mixture was stirred vigorously for 3 hours upon which it was diluted with toluene and 
concentrated by rotatory evaporation.  This was repeated as to remove the TFA.  In vacuo drying 
yielded a white foam 2.11.  This product was analyzed by NMR with no prior purification. 
 
 
 
 
 
(5R,8R)-2,4-Dioxo-1,3,7-triazaspiro[4.5]decane-7,8-dicarboxylic acid 7-benzyl ester  (2.12) 
Compound 2.10 (42 mg, 0.069 mmol) was dissolved in a mixture of 3:7 TFA/DCM (~3.0 mL, 40 
mL per mmol of 2.10) and was transferred to a 25 mL round bottom flask fitted with a stir bar.  
The mixture was stirred vigorously for 3 hours upon which it was diluted with toluene and 
concentrated by rotatory evaporation.  This was repeated as to remove the TFA.  In vacuo drying 
yielded a white foam 2.12.  This product was analyzed by 2D-NMR with no prior purification. 
 
 
 
 
 
 
(2R,5R)-5-Aminopiperidine-1,2,5-tricarboxylic acid 1-benzyl ester 2-tert-butyl ester (2.13) 
Compound 2.9 (8.8 g, 14.6 mmol) was dissolved in THF (58 mL) and transferred to a 250 mL 
round bottom flask.  To this a 2M aqueous KOH solution (58 mL) was added.  The reaction 
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mixture was stirred vigorously for 45 minutes at room temperature.  The solution was transferred 
to a 500 mL separatory funnel and Et2O (200 mL) was added.  The aqueous layer was separated 
into a beaker and cooled to 0 °C with an ice bath.  While under mechanical stirring, dropwise 
addition of 2M HCl resulted in a white precipitate.  The pH was adjusted to 6.5 and monitored 
for 30 minutes.  The solution was filtered through a medium frit sintered glass funnel, and the 
precipitate was washed with ice cold deionized water.  The precipitate was allowed to air dry 
before in vacuo drying over anhydrous calcium sulphate followed by in vacuo drying in an oven 
at 40 °C yielding 2.13 as a white solid (5.27 g, 95.6 % yeld). [α]23D = 14.2° (c 1.0, MeOH); IR 
(film) νmax 2975, 1735, 1690, 1616, 1498, 1432, 1403, 1352, 1222, 1153, 1109; 1H NMR (300 
MHz, 20°C, Ac-d3-OD) δ 7.24-7.31 (m, 5H), δ 5.01-5.15 (br m, 2H), δ 4.73 (br d, 1H), δ 4.35 
(br t, 1H), δ 3.63 (d, 13.8 Hz), δ 2.38 (d, 14.1 Hz), δ 2.00-2.35 (m, 2H), δ 2.75 (m, 1H), δ 1.37 
(m 9H); 13C NMR (75.4 MHz, 20 °C, Ac-d3-OD) δ 177.8, δ 176.9, δ 156.3, δ 136.1, δ 128.4, δ 
128.0, δ 127.8, δ 82.9, δ 68.1, δ ~58, δ ~55, δ ~45, δ 27.1, δ 22.1; HRMS-ES (m/z): 379.1887 
(C19H27N2O6 + Na+ requires 379.1869). 
 
 
  
  
 
(2R,5R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 2-tert-butyl ester (2.14) 
To a 250 mL three neck round bottom flask containing a magnetic stir bar and fitted with a reflux 
condenser and rubber septa were added 2.13 (5.3 g, 13.9 mmol).  This solid was suspended in 
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dry CH2Cl2 (70 mL). DIPEA (6.8 mL, 41.8 mmol) was added followed by the dropwise addition 
of chlorotrimethylsilane (3.7 mL, 29.3 mmol) with venting with a 21G2 precision glide needle.  
The resulting mixture was refluxed with nitrogen for 90 minutes.  The solution was cooled to 0 
°C with an ice bath, and 9-fluorenylmethyl chloroformate (4.0 g, 15.3 mmol) was added in one 
portion.  The solution was warmed to room temperature overnight with stirring.  The solution 
was concentrated by rotary evaporation, dissolved in EtOAc (150 mL), transferred to a 500 mL 
separatory funnel, and washed with 1 M HCl (3 x 75 mL).  The aqueous layers were combined 
and backwashed with EtOAc (2 x 75 mL).  The EtOAc layers were combined and washed with 
brine (3 x 75 mL) and then dried over anhydrous MgSO4, and filtered.  The solution was 
concentrated on a rotary evaporator and subsequently adsorbed onto celite.  This was followed 
with immediate purification by flash chromatography on a Combiflash companion purification 
system (140g silica column, 0-10% MeOH/CHCl3 gradient).  Fractions with pure product were 
combined and solvent removed by rotary evaporation and under reduced pressure overnight to 
yield a white foamy solid 2.14 (5.8 g, 70 % yield). [α]23D = 9.4° (c 1.0, CHCl3); IR (film) νmax 
3307, 3031, 2977, 2359, 2341, 1731, 1525, 1449, 1368, 1327, 1251, 1152, 1089, 1034, 1009, 
757, 741, 697, 668; 1H NMR (300 MHz, 77°C, DMSO-d6) δ 12.2 (br s, 1H), δ 7.86 (d, 7.5 Hz, 
2H), δ 7.68 (d, 7.2, 2H), δ 7.52 (s, 1H), δ 7.28-7.44 (m, 9H), δ 5.10 (br s, 2H), δ 4.67 (d, 13.2 Hz, 
1H), 4.58-4.64 (dd, 1H), δ 4.28-4.33 (m, 2H), δ 4.21 (dd, 1H), δ 2.95 (d, 13.2 Hz, 1H), δ 2.21 (m, 
1H), δ 1.85-2.10 (m, 2H), δ 1.57 (ddd, 3 Hz, 12 Hz, 12 Hz, 1H), δ 1.4 (br s, 9H); 13C NMR (75.4 
MHz, 20 °C, CDCl3) δ 175.2, δ 170.1, δ 156.0, δ 155.3, δ 143.6, δ 141.2, δ 141.1, δ 136.3, δ 
128.3, δ 127.6, δ 127.0, δ 125.0, δ 119.8, δ 82.1, δ 67.6, δ 67.0, δ 56.6, δ 54.0, δ 46.9, δ 46.4, δ 
28.9, δ 28.4, δ 27.9, δ 27.8, δ 27.4, δ 22.6; HRMS-ES (m/z): 601.2585 (C34H37N2O8 + Na+ 
requires 601.2550). 
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(2R,5R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 5-(2,2,3,3 tetrafluoro) propyl ester 2-tert-butyl ester (2.15) 
Compound 2.14 (5.4 g, 9.0 mmol) was dissoloved in dry CH2Cl2 (90 mL) and transferred to a 
250 mL round bottom flask.  To the solution were added DMAP (55 mg, .45 mmol, 0.05 equiv.) 
and 2,2,3,3-tetrafluoro propanol (1.6 mL, 18.1 mmol).  The resulting solution was cooled with an 
ice bath and DCC (2.0 g, 9.5 mmol) was added in one portion.  The reaction was complete after 
5 hours of stirring and was monitored via TLC (5:1 CHCl3/MeOH, visualized under UV).  The 
solution was concentrated by rotary evaporation, the residue dissolved in 1:1 EtOAc/Hexanes 
(75 mL), and then filtered through a medium frit sintered glass funnel to remove byproduct 
DCU.  The filtrate was concentrated by rotary evaporation and subsequently adsorbed on to 
celite.  This was followed with immediate purification by flash chromatography on a Combiflash 
companion purification system (140g silica column, 0-50% EtOAc/Hexanes gradient).  Pure 
fractions of 2.15 were combined, and the solvent removed by rotary evaporation and under 
reduced pressure overnight to yield a foamy white solid (4.8 g, 74% yield). [α]23D = 17.8° (c 1.0, 
CHCl3); IR (film) νmax 3323, 2978, 1761, 1728, 1526, 1450, 1426, 1368, 1321, 1255, 1117, 759, 
741; 1H NMR (300 MHz, 77°C, DMSO-d6) δ 7.91 (d, 7.5 Hz, 2H), δ 7.86 (s, 1H), 7.70 (d, 7.2 
Hz, 2H), δ 7.30-7.50 (m, 9H), δ 6.42 (tt, 5.1 Hz, 47.1 Hz, 1H), δ 5.15 (br s, 2H), δ 4.66-4.76 (m, 
2H), δ 4.47-4.61 (m, 2H), δ 4.40 (d, 2H), δ 4.25 (t, 8.7 Hz, 1H), δ 3.00 (d, br dd, 3.9 Hz, 10.5 Hz, 
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1H), δ 1.89 (m, 1H), δ 1.68 (dd, 3.6 Hz, 12.9 Hz, 1H), δ 1.45 (br s, 9H); 13C NMR (75.4 MHz, 20 
°C, CDCl3) δ 170.1, δ 169.9, δ 155.6 & 155.5 (rotamers), δ 154.9, δ 143.6, δ 141.3, δ 136.2, δ 
128.4, δ 128.0, δ 127.8, δ 127.7, δ 127.0,  δ 124.8, δ 119.9, δ 113.9, δ 108.9, δ 82.2, δ 67.6, δ 
66.9, δ ~61, δ 56.8, δ 53.7, δ 47.0, δ 46.7, δ 29.8, δ 27.9, δ 27.9, δ 27.5, δ 22.6; HRMS-ES (m/z): 
737.2482 (C37H38N2O8F4 + Na+ requires 737.2462). 
 
  
  
  
 
(2R,5R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 5-(2,2,3,3 tetrafluoro) propyl ester (2.16) 
Compound 2.15 (4.4 g, 6.2 mmol) was dissolved in dry CH2Cl2 (25 mL) and TFA (25 mL) and 
stirred vigorously for 2 hours in a 100 mL round bottom flask.  The reaction was monitored via 
TLC (5:1 CHCl3/MeOH, visualized under UV).  The solution was concentrated by rotary 
evaporation and adsorbed onto celite.  This was followed with immediate purification by flash 
chromatography on a Combiflash companion purification system (40g silica column, 0-10% 
MeOH/CHCl3 gradient).  Pure fractions of 2.16 were combined, and the solvent removed by 
rotary evaporation and under reduced pressure overnight to yield a foamy white solid (4.1 g, 
100% yield). [α]23D = 11.2° (c 1.0, CHCl3); IR (film) νmax 3315, 3020, 2955, 1715, 1525, 1449, 
1317, 1256, 1118, 1032, 966, 831, 758, 698, 667, 621; 1H NMR (300 MHz, 77°C, DMSO-d6) δ 
7.90 (d, 7.5 Hz, 2H), δ 7.82 (s, 1H), δ 7.70 (d, 7.2 Hz, 2H), δ 7.30-7.50 (m, 9H), δ 6.41 (tt, 5.1 
Hz, 52.2 Hz, 1H), δ 5.16 (br s, 2H), δ 4.70-4.79 (m, 2H), δ 4.54-4.60 (m, 2H) δ 4.35-4.40 (d, 
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2H), δ (4.24, t, 6.6 Hz), δ 3.05 (br d, 13.5 Hz, 1H), δ 2.22 (br d, 13.5 Hz, 1H) δ 2.11 (br dd. 3.6 
Hz, 10.5 Hzz, 1H), 1.89 (m, 1H), δ 1.67 (ddd, 3.6 Hz, 13.2 Hz, 13.2 Hz, 1H); 13C NMR (75.4 
MHz, 20 °C, CDCl3) δ 175.1, δ 170.0, δ 155.9, δ 155.2, δ 143.4, δ 141.3, δ 135.8, δ 128.4, δ 
128.1, δ 127.7, δ 127.0, δ 124.7, δ 120.0, δ 109.0, δ  ~82, δ 68.0, δ 67.1, δ 60.0, δ 56.5, δ 53.1, δ 
49.9, δ 46.9, δ 33.3, δ 29.8, δ 22.8 and 22.3 (rotamers); HRMS-ES (m/z): 681.1804 
(C33H30N2O8F4 + Na+ requires 681.1836). 
 
 
 
  
 
(2R,5R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
tert-butyl ester 5-(2,2,3,3 tetrafluoro) propyl ester (2.17) 
Compound 2.16 (3.71 g, 5.73 mmol) was dissolved in dry THF (50 mL) and transferred to a 100 
mL round bottom flask.  To the solution were added 10 wt % Pd/C (371 mg, 10% by wt 2.16) 
and di-tert-butyl dicarbonate (3.1 g, 14.1 mmol).  The solution was degassed by vacuum 
filtration and backfilled with H2 via a balloon (cycle repeated 3 times).  The reaction progress 
was monitored via HPLC.  The progress stalled and therefore DIPEA (2.82 mmol, 0.5 equiv) 
was added, and the conversion was completed after 7 hours.  The solution was filtered through 
fluted filter paper, and the residual Pd/C washed repeatedly with CHCl3.  The solution was 
concentrated by rotary evaporation and adsorbed onto celite.  This was followed by immediate 
purification by flash chromatography on a Combiflash companion purification system (40g silica 
comlumn, 0-10% MeOH/CHCl3 gradient). All pure fractions were combined, and the solvent 
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removed by rotary evaporation and under reduced pressure overnight yielding a white foamy 
solid 2.17 (2.2 g, 63 % yield). [α]23D = 14.0° (c 1.0, CHCl3); IR (film) νmax 3306, 3015, 2979, 
1715, 1958, 1477, 1450, 1417, 1394, 1369, 1320, 1255, 1158, 1119, 1030, 759, 741; 1H NMR 
(300 MHz, 77°C, DMSO-d6) δ 7.90 (d, 7.5 Hz, 2H), δ 7.80 (s, 1H), δ 7.71 (d, 8.1 Hz, 2H), δ 
7.32-7.50 (m, 4H), 6.43 (tt, 5.4 Hz, 52.2 Hz, 1H), δ 4.62 (br d, 12.9 Hz, 2H), δ 4.49-4.67 (m, 
3H), δ 4.37 (d, 6.3 Hz, 2H), δ 4.25 (t, 6.6 Hz, 1H), δ 3.00 (d, 6.3 Hz, 1H), δ 2.26 (br d, 13.5 Hz, 
1H), δ 2.06 (dd, 1H), δ 1.83-1.96 (m, 1H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6) δ 172.3, δ 
170.3, δ 155.2, δ 154.1, δ 143.7, δ 140.7, δ 127.6, δ 127.0, δ 125.0, δ 120.1, δ 79.5, δ 79.1, δ 
65.7, δ 59.8, δ 56.5 & 56.4 (rotamers), δ 53.5, δ 46.6, δ 45.8, δ 29.2, δ 28.2, δ 27.8, δ 27.4, δ 
22.2; HRMS-ES (m/z): 647.1996 (C30H32N2O8F4 + Na+ requires 647.1992). 
 
 
 
 
 
(2R,5S)-5-Aminopiperidine-1,2,5-tricarboxylic acid 1-benzyl ester 2-tert-butyl ester (2.18) 
The general procedure for the synthesis of compound 2.13 was followed for the synthesis of 2.18 
(1.0 g, 100% yield, salts were present) starting with compound 2.10 (1.7 g, 2.7 mmol).  [α]23D = 
16.4° (c 1.0, CHCl3); IR (film) νmax 2972, 1731, 1698, 1597, 1532, 1449, 1366, 1325, 1254, 
1210, 1150, 1125; 1H NMR (300 MHz, 20°C, Ac-d3-OD) δ 7.25-7.32 (m, 5H), δ 4.99-5.22 (m, 
2H), δ 4.74-4.76 (rotamers) (m, 1H), δ 4.34 (d, 14.7 Hz, 1H), δ 3.43-3.60 (rotamers) (m, 1H), δ 
1.98-2.20 (m, 4H), δ 1.34-1.37 (m, 9H); 13C NMR (75.4 MHz, 20 °C, Ac-d3-OD) δ 174.0, δ 
170.7 & 170.4 (rotamers), δ 158.0 & 157.9 (rotamers), δ 137.0, δ 129.4, δ 129.2, δ 129.0, δ 
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128.9, δ 83.6, δ 69.1, δ 60.4, δ 55.3 & 54.9 (rotamers), δ 46.6 & 46.3 (rotamers), δ 28.1, δ 28.0, δ 
21.2; HRMS-ES (m/z): 379.1855 (C19H27N2O6 + Na+ requires 375.1869). 
 
 
  
  
  
 
(2R,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 2-tert-butyl ester (2.19) 
The general procedure for the synthesis of compound 2.14 was followed for the synthesis of 2.19 
(1.2 g, 71 % yield) starting with compound 2.18 (1.0 g, 2.7 mmol).  [α]23D = 17.9° (c 1.0, 
CHCl3); IR (film) νmax 3325, 2977, 1731, 1524, 1449, 1368, 1322, 1285, 1249, 1156, 1132, 1071, 
1003, 757, 740, 697; 1H NMR (300 MHz, 77°C, DMSO-d6) δ 7.88 (d, 7.5 Hz, 2H), δ 7.69 (d, 6.9 
Hz, 2H), δ 7.20-7.47 (m, 9H), δ 5.03 (br s, 2H), δ 4.65 (m, 2H), δ 4.2. (br s, 1H), δ 3.32, ( br s, 
2H), δ 1.93-2.30 (m, 3H), δ 1.63 (ddd, 5.1 Hz, 14.7 Hz, 14.7 Hz, 1H), δ 1.41 (br s, 9H); 13C 
NMR (75.4 MHz, 20 °C, CDCl3) δ 176.3 & 175.9 (rotamers), δ 169.5, δ 156.6 & 156.4 
(rotamers), δ 155.7, δ 143.7 &143.5 (rotamers), δ 141.3, δ 135.9, δ 128.5, δ 128.2, δ 128.0, δ 
127.7, δ 127.0, δ 125.0, δ 119.9, δ 82.4, δ 67.9 & 67.1 (rotamers), δ 57.9 & 57.3 (rotamers), δ 
54.5 & 53.9 (rotamers), δ 47.0, δ 46.2, δ 28.0, δ 27.9, δ 27.5, δ 25.6, δ 21.4; HRMS-ES (m/z): 
623.2383 (C34H36N2O8 + Na+ requires 623.2369). 
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(2R,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 5-(2,2,3,3 tetrafluoro) propyl ester 2-tert-butyl ester (2.20) 
The general procedure for the synthesis of compound 2.15 was followed for the synthesis of 2.20 
(1.1g, 87% yield) starting with compound 2.19 (1.1 g, 1.8 mmol).  [α]23D = 18.8° (c 1.0, CHCl3); 
IR (film) νmax 3324, 3016, 2977, 2942, 1760, 1731, 1524, 1450, 1394, 1369, 1286, 1188, 1155, 
1112, 1081, 1014, 966, 845, 829, 758, 742, 697; 1H NMR (300 MHz, 77°C, DMSO-d6) δ 7.86 
(d, 7.5 HZ, 2H), δ 7.76 (br s, 1H), δ 7.65 (d, 6.9 Hz, 2H), δ 7.21-7.46 (m, 9H), δ 6.41 (tt, 4.8 Hz, 
52.2 Hz, 1H), δ 5.05 (br s, 2H), δ 4.72 (d, 1H), δ 4.48-4.64 (m, 3H), 4.15-4.29 (m, 3H), δ 3.31 
(br s, 1H), δ 1.91-2.18 (m, 3H), δ 1.65 (m, 1H), δ 1.42 (br s, 9H); 13C NMR (75.4 MHz, 20 °C, 
CDCl3) δ 170.4, δ 169.4, δ 156.5 & δ 156.1, δ 155.1, δ 143.6, δ 141.3, δ 135.9, δ 128.5, δ 128.3, 
δ 128.0, δ 127.7, δ 127.0, δ 124.9, δ 120.0, δ 113.8, δ 82.5, δ 67.9, δ 67.0, δ 60.4, δ 58.0 & 57.5 
(rotamers), δ 54.4 & 53.7 (rotamers), δ 47.3 & 47.1 (rotamers), δ 46.1, δ 28.3, δ 27.9, δ 27.8, δ 
25.6, δ 21.3; HRMS-ES (m/z): 737.2422 (C37H38N2O8F4 + Na+ requires 737.2462). 
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(2R,5S)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
benzyl ester 5-(2,2,3,3 tetrafluoro) propyl ester (2.21) 
The general procedure for the synthesis of compound 2.16 was followed for the synthesis of 2.21 
(0.83g, 92% yield) starting with compound 2.20 (1.0 g, 1.4 mmol).  [α]23D = 11.3° (c 1.0, 
CHCl3); IR (film) νmax 3323, 3032, 2952, 1717, 1517, 1449, 1284, 1112, 1013, 965, 859, 831, 
741, 697, 667; 1H NMR (300 MHz, 77°C, DMSO-d6) δ 7.86 (d, 7.5 Hz, 2H), δ 7.76 (br s, 1H), δ 
7.65 (d, 7.2 Hz, 2H), δ 7.21-7.45 (m, 9H), δ 6.41 (tt, 4.8 Hz, 52.2 Hz, 1H), δ 5.05 (br s, 2H), δ 
4.80 (br d, 4.8 Hz, 1H), δ 4.47-4.64 (m, 3H), δ 4.15-4.28 (m, 3H), δ 3.35 (br s, 1H), δ 1.93-2.19 
(m, 3H), δ 1.69 (m, 1H); 13C NMR (75.4 MHz, 20 °C, CDCl3) δ 175.2 & 174.8, δ 170.3, δ 156.5, 
δ 155.4, δ 143.4, δ 141.3, δ 135.6, δ 128.5, δ 128.2, δ 127.9, δ 127.7, δ 127.0, δ 120.0, δ 113.8, δ 
109.2, δ 105.8, δ 68.2, δ 67.0, δ 60.2, δ 57.9 & 57.2 (rotamers), δ 53.6 & 53.0 (rotamers), δ 47.0, 
δ 45.8, δ 27.6, δ 20.9; HRMS-ES (m/z): 681.1793 (C33H30N2O8F4 + Na+ requires 681.1836). 
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(2R,5R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-piperidine-1,2,5-tricarboxylic acid 1-
tert-butyl ester 5-(2,2,3,3 tetrafluoro) propyl ester (2.22) 
The general procedure for the synthesis of compound 2.17 was followed for the synthesis of 2.22 
(.32 g, 51 % yield) starting with compound 2.21 (.66 g, 1.0 mmol).  [α]23D = 4.27° (c 0.5, 
CHCl3); IR (film) νmax 3323, 2976, 1757, 1716, 1521, 1450, 1477, 1394, 1368, 1267, 1185, 1154, 
1113, 1014, 965, 851, 759, 666, 620; 1H NMR (300 MHz, 77°C, DMSO-d6) δ 7.91 (d, 7.5 Hz, 
2H), δ 7.72 (d, 7.5 Hz, 2H), δ 7.32-7.50 (m, 4H), δ 6.45 (tt, 5.1 Hz, 52.2 Hz, 1H), δ 4.50-4.80 (m, 
4H), δ 4.21-4.49 (m, 3H), δ 3.55-3.78 (m, 1H), 1.94-2.14 (m 3H), δ 1.0-1.76 (m, 1H), δ 1.40 (br 
s, 9H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6) δ 172.5, δ 171.4, δ 155.3, δ 154.3, δ 143.3, δ 
140.4, δ 127.8, δ 126.3, δ 125.7, δ 120.9, δ 118.8, δ 80.3, δ 78.8, δ ~67.0, δ ~59.5, δ 56.5, δ 
5436, δ 52.3, δ 46.3, δ 45.4, δ 28.4, δ 26.7, δ ~21; HRMS-ES (m/z): 647.2.  
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(2R,4R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-proline-1,2,4-tricarboxylic acid 1-
benzyl ester 4-(2,2,3,3 tetrafluoro) propyl ester 2-tert-butyl ester (2.24) 
The general procedure for the synthesis of compound 2.15 was followed for the synthesis of 2.24 
(1.7 g, 70% yield) starting with compound (2R,4R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-
proline-1,2,4-tricarboxylic acid 1-benzyl ester 2-tert-butyl ester (2.0 g, 3.4 mmol).  [α]23D = -3.0° 
(c 1.0, CHCl3); IR (film) νmax 3313, 2978, 1710, 1525, 1450, 1419, 1356, 1258, 1156, 1109, 961, 
831, 758, 741, 697; 1H NMR (300 MHz, 77°C, DMSO-d6) δ 8.02 (br s, 1H), δ 7.86 (d, 7.5 Hz, 
2H), δ 7.68 (d, 3.6 Hz, 7.5 Hz, 2H), δ 7.30-7.45 (m, 9H), δ 6.42 (tt, 5.1 Hz, 52.2 Hz, 1H), δ 5.11 
(br s, 2H), δ 4.60 (t, 13.8 Hz, 2H), δ 4.31-4.47 (m, 3H), δ 4.22 (t, 6.3 Hz, 1H), δ 4.08 (d, 11.4 Hz, 
1H), δ 3.67 (d, 11.4 Hz, 1H), δ 2.87 (br m, 1H), δ 2.35 (br d, 8.7 Hz), δ 1.38 (br s, 9H); 13C NMR 
(300 MHz, 22°C, DMSO-d6) δ 170.8, δ 170.3, δ 155.8, δ 154.0, δ 144.1, δ 141.2, δ 137.0, δ 
128.3, δ 128.2, δ 127.8, δ 127.7, δ 127.6, δ 127.5, δ 127.3, δ 127.2, δ 127.0, δ 125.6, δ 120.5, δ 
114.6, δ 111.6 & 109.7 & 107.7, δ 81.6, δ 66.8, δ 63.6 & 62.7, δ 60.9 & 60.6 (rotamers), δ 58.8 
& 58.4 (rotamers), δ 55.0 & 54.6 (rotamers), δ 47.0, δ 38.9 & δ 37.8 (rotamers), δ 27.9, δ 27.8; 
HRMS-ES (m/z): 723.2319 (C36H36N2O8F4 + Na+ requires 723.2305). 
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(2R,4R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-proline-1,2,4-tricarboxylic acid 1-
benzyl ester 4-(2,2,3,3 tetrafluoro) propyl ester (2.25) 
The general procedure for the synthesis of compound 2.16 was followed for the synthesis of 2.25 
(1.1 g, 94% yield) starting with compound 2.24 (1.3 g, 1.9 mmol).  [α]23D = 22.7° (c 1.0, CHCl3); 
IR (film) νmax 3304, 3034, 1716, 1521, 1419, 1260, 1109, 741, 697; 1H NMR (300 MHz, 77°C, 
DMSO-d6) δ 8.08 (br s, 1H), δ 7.86 (d, 7.5 Hz, 2H), δ 7.67 (d, 7.5 Hz, 2H), δ 7.30-7.44 (m, 9H), 
δ 6.41 (tt, 5.1 hz, 52.2 Hz, 1H), δ 5.10 (br s, 2H), δ 4.58 (t, 14.1 Hz, 2H), δ 4.34-4.39 (m, 3H), δ 
4.11-4.25 (m, 2H), δ 3.59 (d, 11.7 Hz, 1H), δ 2.87 (br m, 1H), δ 2.31 (br dd, 6.3 Hz, 13.5 Hz, 
1H); 13C NMR (300 MHz, 22°C, DMSO-d6) δ 173.2, δ 172.8, δ 171.0, δ 156.4, δ 154.1 & 153.9, 
δ 144.1, δ 141.2, δ 137.1, δ 128.9, δ 128.8, δ 128.4, δ 128.2, δ 128.0, δ 127.6, δ 127.5, δ 125.6, δ 
120.6, δ 114.8, δ 109.6, δ 66.9, δ 66.4, δ 63.4, δ 62.6 & 61.0 (rotamers), δ 60.8, δ 58.1 & 57.8 
(rotamers), δ 55.2 & 54.8 (rotamers), δ 47.0, δ 39.1 & δ 38.0 (rotamers); HRMS-ES (m/z): 
667.1699 (C32H28N2O8F4 + Na+ requires 667.1679). 
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(2R,4R)-5-(9H-Fluoren-9-ylmethoxycarbonylamino)-proline-1,2,4-tricarboxylic acid 1-tert-
butyl ester 4-(2,2,3,3 tetrafluoro) propyl ester (2.26) 
Compound 2.25 (1.0 g, 1.6 mmol) was dissolved in dry THF (30 mL) and transferred to a 100 
mL round bottom flask.  To the solution were added 10 wt % Pd/C (.1 g, 10% by wt 2.25) and 
di-tert-butyl dicarbonate (.85 g, 3.9 mmol).  The solution was degassed by vacuum filtration and 
backfilled with H2 via a balloon (cycle repeated 3 times).  The reaction progress was monitored 
via HPLC.  The reaction was complete after 24 hours.  The solution was filtered through fluted 
filter paper, and the residual Pd/C washed repeatedly with CHCl3.  The solution was 
concentrated by rotary evaporation and adsorbed onto celite.  This was followed by immediate 
purification by flash chromatography on a Combiflash companion purification system (40g silica 
comlumn, 0-10% MeOH/CHCl3 gradient). All pure fractions were combined, and the solvent 
removed by rotary evaporation and under reduced pressure overnight yielding a white foamy 
solid 2.26 (.85 g, 90 % yield). [α]23D = 51.0° (c 1.0, CHCl3); IR (film) νmax 3304, 2979, 1699, 
1530, 1478, 1451, 1409, 1369, 1259, 1109, 830, 759, 742; 1H NMR (300 MHz, 22°C, DMSO-
d6) ; δ 8.44 (s, 1H), δ 7.89 (d, 4.5 Hz, 2H), δ 7.70 (d, 4.5 Hz, 2H), δ 7.31-7.43 (m, 4H), δ 6.35-
6.60 (m, 1H), δ 4.63 (t, 8.1 Hz, 2H), δ 4.28-4.32 (m, 2H), δ 4.21 (t, 4.2 Hz, 1H), δ 4.17 (t, 4.5 Hz, 
1H), δ 4.08 (rotamer, d, 1H), δ 4.01 (rotamer, d, 1H), δ 3.42-3.45 (rotamers, 2H), δ 2.76-2.87 
(rotamer, 1H), δ 2.19-2.29 (rotamer, 1H), δ 1.35-1.40 (rotamer, 9H); 13C NMR (300 MHz, 22°C, 
N
OH
O
HN
O
O Fmoc
F
FF
F
Boc
2.26
 77 
DMSO-d6) δ 174.0, δ 171.0, δ 156.4, δ 153.6, δ 144.1, δ 141.2, δ 128.4, δ 127.6, δ 125.6, δ 
120.6, δ 114.8, δ109.6, δ 79.7 & 79.1, δ 66.4, δ 63.2 & 62.5 (rotamers), δ 60.7, δ 58.4 & 58.1 
(rotamers), δ 55.1 & 54.7 (rotamers), δ 47.0, δ 38.4 & δ 37.9 (rotamers); HRMS-ES (m/z): 
633.1822 (C29H30N2O8F4 + Na+ requires 633.1836). 
5.2 CHAPTER 3 
General:  Solid phase chemistry was carried out using a home-made solid phase peptide 
synthesizer.  Anhydrous DMF used in coupling reactions was purchased from Aldrich Chemical 
Company.  Dry CH2Cl2 was distilled from CaH2 and used for coupling reactions.  
Diisopropylethyl amine (DIPEA) was distilled under N2 first from ninnydrin and secondly from 
KOH and stored over molecular sieves (4A).  O-(7-azabenzotriazol-1-yl)-N,N,N’,N’-
tetramethyluronium hexafluorophosphate (HATU) was purchased from Aldrich or GenScript 
Coorporation.  1-(mesitylene-2-sulfonyl)-3-nitro-1,2,4-triazole was purchased from Acros.  The 
hydroxymethyl polystyrene resin was purchased from NovaBiochem.  N-α-Fmoc-O-t-butyl-L-
tyrosine was purchased from NovaBiochem.  The Pf1 bacteriophage was purchased from Asla 
Biotech.  All other reagents were purchased from Aldrich or Acros and used as received.  All 
solid phase reactions were mixed by agitation with bubbling argon thus maintaining a constant 
argon atmosphere.  HPLC-MS analysis was performed on a Hewlett-Packard Series 1050 
instrument with a diode array detector, HP 1100 MS detector (ESI), using a Waters Xterra MS 
C18 column (3.5 μm packing, 4.6 X 100 mm).  Purification by preparative HPLC was performed 
on a Varian Prostar 500 HPLC system with a Waters Xterra MS C18 column (5 μm packing, 30 
X 100 mm) or a Waters Xterra MS C18 column (5 μm packing, 10 x 100 mm).  NMR 
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experiments were performed on Bruker Advance DRX 600 MHz spectrometer or a Bruker 
Advance DRX 700 MHz with a cryoprobe.  Chemical shifts are reported relative to a 
(trimethylsilyl)propionic-2,2,3,3-d4 acid.  1H and 13C assignment was carried out with Sparky 3, 
T. D. Goddard and D.G. Kneller, University of California, San Francisco.  REDCAT was used 
for analysis of the residual dipolar coupling values and ACME used for 3JHH coupling extraction. 
 
Synthesis of pip5(2S5R)-pip5(2R5S)-pro4(2S4S)-(L)-tyrosine 
 
 
To a 10 mL polypropylene solid phase peptide synthesis (SPPS) reaction vessel was added 
hydroxymethyl polystyrene resin (30 mg, 0.98 mmol/g substitution).  The resin was swelled in 
DCM for 1 hour.  In a 2 mL polypropylene micro centrifuge vial pip5(2S5R) Boc-monomer 
(91.8 mg, 147 μmol) was dissolved in dry DCM (588 μL) and MeIm (8.8 μL, 111 μmol) was 
added.  To this solution was added MSNT (43.6 mg, 147 μmol).  The resulting solution was 
transferred to the SPPS reaction vessel and was mixed with gently bubbling argon for 1 hour.  
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This procedure was repeated.  The resin was washed repeatedly with DCM and IPA and then 
DMF and MeOH to assure the removal of residual reactants.  The resin was swelled in DMF for 
ten minutes.  The terminal Fmoc protecting group was removed with 20% piperidine in DMF for 
30 minutes and analysis by UV-Vis of the piperidine-dibenzofulvene adduct (λmax=301 nm, ε = 
7800 M-1cm-1) indicated near quantitative coupling to the resin. The remaining pip5(2R5S) Boc-
monomer,  pro4(2S4S) Boc-monomer, and N-α-Fmoc-O-t-butyl-L-tyrosine were coupled 
sequentially to the resin (2 eq. of N-Fmoc protected monomer, 2 eq. of HATU, 4 eq. of DIPEA, 
0.2 M in 20%DCM/DMF, 30 minute reaction time).  Every monomer coupling was repeated 
once as to insure complete coupling.  After the double couplings the resin was washed with DMF 
and then capped with a 400:100:8 DMF:Ac2O:DIPEA solution for ten minutes.  The terminal 
Fmoc protecting group was removed with 20% piperidine in DMF for 30 minutes and  UV-Vis 
spectroscopic analysis of the piperidine-dibenzofulvene adduct (λmax=301 nm, ε = 7800 M-1cm-1) 
was used to quantitate overall couplings.  After the removal of the last terminal Fmoc group, the 
resin was swelled in DCM and treated twice with 50% TFA/DCM for 30 minutes to remove the 
Boc protecting groups on all secondary amines.  The resin was neutralized with 10% TEA/DCM 
and washed repeatedly with DCM and MeOH.  Residual solvent was removed under reduced 
pressure.  The dry resin beads were transferred to a 10 mL microwave reaction vessel fitted with 
a stir bar.  5 mL of a solution of 100 mM AcOH and 50 mM Et3N in o-xylene was added, and the 
vessel was capped and placed in a microwave reactor (CEM Discover) and irradiated (300 W 
max power, 130 °C, 5 min ramp) with continuous stirring for 30 minutes.  The resin was then 
transferred to a 10 mL SPPS polypropylene reactor and washed repeatedly with DCM and 
MeOH.  Residual solvent was removed under reduced pressure.  To the dry resin was added 1 
mL TFA, 60 μL thioanisole, and 30 μL EDT.  The solution was cooled in an ice bath while being 
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stirred.  To the cleavage solution was added 60 μL TFMSA, and the resulting solution was 
stirred vigorously for 3 hours.  The product was precipitated in 40 mL of anhydrous diethyl ether 
while stirring.  The resulting precipitate was pelleted by centrifugation, and the ether decanted.  
The pellet was dissolved in 1:1 H2O/MeCN (1 mL) and purified by preparative HPLC.  The 
desired fractions were pulled together and concentrated by freeze-drying. 
 
2-D NMR experiments on 3.1 
1H, HMBC, and TOCSY NMR experiments on a 5 mM solution of 3.1 and HSQC-F1 dimension 
no decoupling and ROESY NMR experiments on a 11 mM solution of 3.1 in 90% H2O/D2O with 
20 mM acetate buffer at pH 3.4.  Software package Sparky was used to assign the oligomer. 
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HPLC-MS: column, Waters XTerra MS C18 column; mobile phase , MeCN/water (0.1% 
formic acid), 0% to 25% MeCN over 30 minutes; flow rate, 0.4 mL/min; UV detection at 
274 nm; tR 18.152 min; ES-MS m/z (ion)  624.2 (M+H+). 
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Phase-Sensitive COSY 
A phase-sensitive COSY with States acquisition mode (256 data points in F1 and 4K data points 
in the F2 dimension zero filed back to 4K for a resolution of 1.36 Hz/point) was acquired on a 
7.0 mM solution of 3.1 in D2O with 40 mM phosphate buffer at pH 7.5.  Using the software 
package ACME, the 3JHH coupling constants of each observed multipet were extracted. 
 
Preparation of unaligned NMR sample and HSQC acquisition 
A 6.66 mM solution of 3.1 (2.00 umoles) was prepared in 40 mM phosphate buffer (300 μL) at a 
pH of 7.5.  The solution was added to a Shigemi tube with an elongated glass pipette.  An HSQC 
with the 180 ° pulse on the 1H channel during the t1 evolution period and decoupling during 
signal acquisition eliminated was acquired with 4k data points in the F1 dimension zero filed 
back to 4k and 4k data points in the F2 dimension. 
 
Preparation of Pf1 phage stock solution 
150 μL of a Pf1 magnetic resonance co-solvent was added to a 15 mL Biomax filter with a 10 
NMWL membrane.  To this was added 1 mL of D2O followed by rapid mixing with a disposable 
pipette.  The sample was spun down at 3200 rpm at 4 C° for 2 hours.  Subsequently, another 1 
mL of D2O was added followed my mixing.  The sample was spun down once again at 3200 rpm 
at 4 C° for 4.5 hours.  To this concentrated Pf1 solution was added 200 μL of 40 mM phosphate 
buffer at pH 7.5.  The concentration of Pf1 solution was determined to be 26.33 mg/mL by UV-
VIS absorbance (270 nm, 2.25 mL*mg-1*cm-1). 
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Preparation of Pf1 aligned NMR sample and HSQC acquisition 
To the above 6.66 mM solution of 3.1 in 300 μL of 40mM phosphate buffer at pH 7.5 was added 
183.7 μL of the prepared Pf1 phage stock solution (26.33 mg/mL) to create a 10mg/mL phage 
sample in the now 4.14 mM sample of 3.1. An HSQC with the 180 ° pulse on the 1H channel 
during the t1 evolution period and decoupling during signal acquisition eliminated was acquired 
with 4k data points in the F1dimension zero filed back to 4k and 2k data points in the F2 
dimension. 
5.3 CHAPTER 4 
General:  Solid phase chemistry was carried out using a home-made solid phase peptide 
synthesizer.  Anhydrous DMF used in coupling reactions was purchased from Aldrich Chemical 
Company.  Dry CH2Cl2 was distilled from CaH2 and used for coupling reactions.  
Diisopropylethyl amine (DIPEA) was distilled under N2 first from ninnydrin and secondly from 
KOH and stored over molecular sieves (4A).  O-(7-azabenzotriazol-1-yl)-N,N,N’,N’-
tetramethyluronium hexafluorophosphate (HATU) was purchased from Aldrich or GenScript 
Coorporation.  The dansyl novatag resin was purchased from NovaBiochem.  N-α-Fmoc-N-γ-1-
(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-diaminobutanoic acid, N-α-Fmoc-
N-δ-4-methyltrityl-L-ornithine, and N-α-Fmoc-N-ε-4-methyltrityl-L-diaminoproprionic acid 
were purchases from NovaBiochem.  (S)-N-Fmoc-1-naphthylalanine was purchased from Acros.  
The 3-carboxy-2-fluorophenylboronic acid was purchased from AsymChem.  All other reagents 
were purchased from Aldrich or Acros and used as received.  All solid phase reactions were 
mixed by agitation with bubbling argon thus maintaining a constant argon atmosphere.  HPLC-
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MS analysis was performed on a Hewlett-Packard Series 1050 instrument with a diode array 
detector, HP 1100 MS detector (ESI), using a Waters Xterra MS C18 column (3.5 μm packing, 
4.6 X 100 mm).  Purification by preparative HPLC was performed on a Varian Prostar 500 
HPLC system with a Waters Xterra MS C18 column (5 μm packing, 30 X 100 mm) or a Waters 
Xterra MS C18 column (5 μm packing, 10 x 100 mm).  Fluorescence excitation spectra were 
obtained on a Cary Eclipse Fluorescence spectrophotometer. 
 
Synthesis of 2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid (4.1) 
The 3-carboxy-2-fluorophenylboronic acid (63 mg, 0.33 mmol) was transferred to a 25 mL 
round bottom flask.  To the same round bottom flask was added pinacol (39.4 mg, 0.33 mmol).  
The solids were suspended in a 1:1 mixture of toluene/THF (8 mL).  The solvent was removed 
under reduced pressure by rotary evaporation (20 C°) to yield a white powder.  The process of 
solvent evaporation was repeated three times to yield 4.1 in quantitative amounts.  The product 
was not purified and was used as generated. 
1H NMR (300 MHz, 77 °C, DMSO-d6) δ 7.95 (br t, 1H), δ 7.80 (br t, 1H), δ 7.28 (t, 7.14 Hz, 
1H), δ 1.28 (s, 12H); 13C NMR (75.4 MHz, 20 °C, DMSO-d6) δ 167.09, δ 165.64, δ 163.62, 
δ141.15, δ135.66, δ 124.56, δ 120.10, δ 84.41, δ 25.07. 
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Synthesis of Glucose Actuator Molecule (4.3) 
 
 
 
 
 
 
 
 
 
To a 10 mL polypropylene solid phase peptide synthesis (SPPS) reaction vessel was added 
dansyl novatag resin (25 mg, 0.51 mmol/g substitution).  The resin was swelled in DMF for 1 
hour followed by deprotection of the terminal Fmoc protecting group with 20% piperidine in 
DMF for 30 minutes.  In a 2 mL polypropylene micro centrifuge vial N-α-Fmoc-N-γ-1-(4,4-
dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl-L-diaminobutanoic acid (25.5 μmol) and 
HATU (25.5 μmol) (2 eq. of N-Fmoc protected acid, 2 eq. of HATU ) were dissolved in 
20%DMF/DCM (127 μL).  To this was added DIPEA (4 eq).  The resulting solution was 
transferred to the SPPS reaction vessel and was mixed with gently bubbling argon for 30 min.  
This coupling procedure was repeated.  The resin was washed with DMF and then capped with a 
400:100:8 DMF:Ac2O:DIPEA solution for 10 minutes.  The terminal Fmoc protecting group was 
removed with 20% piperidine in DMF for 30 minutes and  UV-Vis spectroscopic analysis of the 
piperidine-dibenzofulvene adduct (λmax=301 nm, ε = 7800 M-1cm-1) indicated quantitative 
coupling.  The resin was subsequently washed with DMF and IPA and then swelled in DMF for 
N
S O
O
NH
NH
O HN
HN
O
F
B OH
HO
O
N
H
NHN
O
O
NHN
O
O
N
HN
O
O
NH
HN
O
O
N
H
O
HN N
HN
O
O
N
H
N
O
O
N
H
N
O
O
NH
H
N O
O
NH
O
H
N
O
B
F
HO
OH
4.3
 85 
10 minutes.  Next the pro4(2R4R) Boc-monomer, pro4(2R4R) Boc-monomer, pro4(2R4R) Boc-
monomer, pro4(2R4R) Boc-monomer, and N-α-Fmoc-N-δ-4-methyltrityl-L-ornithine were 
coupled sequentially to the resin (2 eq. of N-Fmoc protected acid, 2 eq. of HATU, 4 eq. of 
DIPEA, 0.2 M in 20%DCM/DMF, 30 minute reaction time).  Every coupling was repeated once 
as to insure complete coupling.  After the double couplings the resin was washed with DMF and 
then capped with a 400:100:8 DMF:Ac2O:DIPEA solution for 10 minutes.  The terminal Fmoc 
protecting group was removed with 20% piperidine in DMF for 30 minutes except that of the N-
α-Fmoc-N-δ-4-methyltrityl-L-ornithine which was removed for 2 hours in order to insure 
complete DKP closure between residues.  The resin was washed with DMF and IPA repeatedly 
and then DCM and MeOH followed by swelling in DCM.  The resin was treated with 1% 
TFA/DCM for two minutes for a repetition of 10 times.  After washing with DCM and MeOH, 
DMF and IPA, and swelling in DMF for 10 mintues; the pro4(2R4R) Boc-monomer, pro4(2R4R) 
Boc-monomer, pro4(2R4R) Boc-monomer, pro4(2R4R) Boc-monomer, and N-α-Fmoc-N-ε-4-
methyltrityl-L-diaminoproprionic acid were coupled sequentially to the resin (2 eq. of N-Fmoc 
protected acid, 2 eq. of HATU, 4 eq. of DIPEA, 0.2 M in 20%DCM/DMF, 30 minute reaction 
time).  Every coupling was repeated once as to insure complete coupling.  After the double 
couplings the resin was washed with DMF and then capped with a 400:100:8 DMF:Ac2O:DIPEA 
solution for 10 minutes.  The terminal Fmoc protecting group was removed with 20% piperidine 
in DMF for 30 minutes except that of the N-α-Fmoc-N-ε-4-methyltrityl-L-diaminoproprionic 
acid  which was removed for 2 hours in order to insure complete DKP closure between residues.  
The resin was washed with DMF and IPA repeatedly and then DCM and MeOH followed by 
swelling in DCM.  The resin was treated with 1% TFA/DCM for two minutes for a repetition of 
10 times.  After washing with DCM and MeOH, DMF and IPA, and swelling in DMF for 10 
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mintues; the remaining (S)-N-Fmoc-1-naphthylalanine was coupled (2 eq. of N-Fmoc protected 
acid, 2 eq. of HATU, 4 eq. of DIPEA, 0.2 M in 20%DCM/DMF, 30 minute reaction time) as 
done in previous couplings.  The terminal Fmoc protecting group was removed by treatment with 
20% piperidine in DMF for 30 minutes.    
 
Removal of ivDde protecting group from Dab residue 
A 10 mol solution of 4.5:1:4 Allyl alcohol:hydrazine:DMF was made.  The resin was swelled in 
DMF prior to treatment and was treated with 1 mL of this solution 10 times for 3 minutes each 
treatment.  The resin was then subsequently washed with DMF and IPA and then swelled in 
DMF for 10 minutes. 
 
Coupling of Pinacol Boronate 4.1 
To the remaining two free amines of the scaffold was coupled the pinacol boronate (5 eq to 25 
mg resin, 5 eq. of HATU, 10 eq. of DIPEA, 0.2 M in 20%DCM/DMF, 1 hour reaction time).  
The coupling was repeated five times to insure complete coupling to the free primary and 
secondary amine.  The resin was then washed thoroughly with DMF and IPA and subsequently 
swelled in DMF for 10 minutes. 
 
Deprotection of Pinacol Boronate 
To the resin was added 1 mL of 10% N-methyl-diethanolamine in DMF and was mixed with 
agitation by bubbling argon. The solution was drained and refilled every 20 minutes for 2 hours.  
The resin was then washed with DMF.  Next was added 1 mL of 10% 2M HCl in DMF and was 
mixed with agitation by bubbling argon.  The solution was drained and refilled every 15 minutes 
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for 2 hours.  The resin was subsequently washed repeatedly with DMF and IPA followed by 
DCM and MeOH.  Residual solvent was removed under reduced pressure. 
 
Cleavage of Scaffold from Resin 
To the dry resin was added 600 μL of a 95% TFA, 2,5% TIPS, and 2.5% H2O solution.  The 
SPPS reactor was fitted with a stir bar and was stirred for 3 hours.  After this time, the cleavage 
solution was dripped into a 15 mL Falcon tube.  The TFA was evaporated under a constant 
stream of N2.  The remaining residue was dissolved in 1.6 mL of extra dry NMP, transferred to a 
HPLC glass vial, and was analyzed by HPLC-MS. 
 
 
Solution DKP closure 
 
To the NMP solution of cleaved product was added 400 μL of redistilled piperidine.  The 
solution was stirred under nitrogen overnight.  The DKP closure was found to be complete and 
the product was precipitated in 35 mL of cold ether.  The precipitate was pelleted by 
HPLC-MS: column, Waters XTerra MS C18 column; mobile phase , MeCN/water 
(0.1% formic acid), 5% to 50% MeCN over 30 minutes; flow rate, 0.4 mL/min; UV 
detection at 274 nm; tR 16.111 min; ES-MS m/z (ion) 1210 (M+2H+); m/z ion 807.5 
(M+3H+); m/z ion 605.8 (M+4H+). 
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centrifugation and was purified by preparative HPLC.  The desired fractions were pulled together 
and concentrated by freeze-drying. 
 
 
 
 
 
General Procedure: Saccharide Fluorescence Titrations 
Fluorescence excitation spectra were obtained on a Cary Eclipse Fluorescence 
spectrophotometer.  The excitation and emission slits were set to 5 nm.  Emission was monitored 
at 520 nm and samples irradiated between 270 and 450 nm at a scan rate of 120 nm/min.  
Samples were measured in a 1 cm quartz cell (NSG Precision Cells, Inc.).  The concentration of 
glucose sensor was determined to be 10 μM for each titration in 0.1 M phosphate buffer at pH 
7.4.  The saccharide was added as a small concentrated solution (ranging from 0-100 mmol).  
Each titrated sample was scanned five times sequentially, and these five scans were averaged.  
The excitation spectra were normalized so that the emission maximum of the dansyl group (337 
nm) was 100 units for all samples. 
HPLC-MS: column, Waters XTerra MS C18 column; mobile phase , MeCN/water 
(0.1% formic acid), 5% to 95% MeCN over 30 minutes; flow rate, 0.4 mL/min; UV 
detection at 274 nm; tR 11.554 min; ES-MS m/z (ion) 1114.5 (M+2H+); m/z ion 743.5 
(M+3H+). 
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NMR titration of 3-carboxy-2-fluorophenyl boronic acid with glucose 
1H NMR experiments were performed on a Bruker Advance 300 MHz NMR.  Upon addition of 
glucose to a solution of 3-carboxy-2-fluorophenyl boronic acid in H2O, the chemical shifts of the 
aromatic protons are shifted upfield.  The reversible binding between the boronic acid and 
glucose is slower than the NMR timescale giving rise to the occurrence of two sets of aromatic 
proton peaks.   
A total of 9 samples of 3-carboxy-2-fluorophenyl boronic acid and glucose were made.  
Each NMR sample contained a total concentration of 5.4 mM of 3-carboxy-2-fluorophenyl 
boronic acid in D2O phosphate buffer at a pH of 7.4.  Each NMR sample contained a different 
concentration of glucose (21.7 mM, 43.5 mM, 65.2 mM, 87.0 mM, 108.4 mM, 163.0 mM, 217.4 
mM, 271.1 mM, and 380.4 mM).   
The particular proton resonance monitored in this study was δ 7.13.  The new proton 
resonance that was generated from the glucose bond boronic acid was δ 6.99.  These peaks were 
integrated from each NMR sample listed above.  The integral ratio between the two different 
resonances were plotted vs. the ln[glucose concentration].   
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The Kd occurs at when the boronic acid is half-bound to glucose.  Using equation y=0.141ln(x) – 
0.0193 and substituting 0.5 for y, the Kd was deteremined to be ~40 mM. 
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